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There is an exponential rise in the prevalence of obesity in Singapore coincident 
with the rapid nutritional and socio-economic transition. Significant ethnic 
differences in obesity predisposition exist. Reduced resting energy expenditure 
(REE) and metabolic flexibility (MF) in substrate switching may be contributing 
factors. Multiple single nucleotide polymorphisms (SNPs) in the first intron of 
FTO (fat mass and obesity associated) gene are found to be associated with an 
increase in body mass index (BMI), however the underlying mechanisms by 





This thesis aims to  
 
1) Evaluate differences in REE and MF among Chinese, Malay and Indian 
men. 





268 Chinese, Malay and Indian men aged 21-40 years old, BMI of 18.5 to 30.0 
kg/m2 and have sedentary lifestyles were recruited in this cross sectional study.  
Body composition was measured by dual energy X-ray absorptiometry. Energy 
expenditure and respiratory quotient (RQ) were assessed by indirect calorimetry 
 x
at fasting and during a mixed meal tolerance test. FTO function was explored 
using two approaches a) genetic approach by gene silencing and b) chemical 






1) After adjustment for body weight, REE was significantly lower (73±22 
kcal/day) in Asian-Indians than in Chinese. The association between REE 
and ethnicity was no longer statistically significant after total FFM was 
replaced by trunk FFM (which includes heart, liver, kidney and spleen) 
but not when it was replaced by limb FFM (skeletal muscle).  Among lean 
subjects, the RQ (iAUC) was significantly lower in Chinese (0.010 ± 
0.004) compared with Asian-Indians (0.035±0.005, P<0.001) or Malays 
(0.037±0.005, P<0.001). Among overweight/obese subjects, there were no 
ethnic differences observed for RQ (iAUC). 
2) FTO knockdown and CA treatment in primary human myotubes induced 
gene expression of UCP3, CPT1B, HADHA, ATP5J2 and PGC1A but 
downregulated gene expression of ACC1 and FASN. In CA treated 
myotubes, a significant increase in mitochondrial respiration was 
observed, in particular spare respiratory capacity. CA was also able to 









We have found that Asian Indian men exhibit lower REE than Chinese men for 
the same body weight, which may contribute to the higher prevalence of obesity 
in this ethnic group.  Lower REE in Asian-Indian men may be mediated by 
smaller size of high metabolic rate organs in the trunk and the brain. To prevent 
obesity in Asian-Indians, the recommended dietary allowance for energy intake 
should take into account the lower REE in this ethnic group. In addition, the 
relationship between MF and obesity is modulated by ethnicity. In lean 
individuals, Chinese had lower MF than Malays and Indians.  However, in 
overweight/obese individuals, MF was similar between ethnic groups.  
 
Inhibition of FTO catalytic activity by CA increased fatty acid oxidation, and 
decreased de novo lipogenesis in human skeletal muscle. CA also improved 
mitochondrial oxidative metabolism and basal glucose uptake. Collectively, these 
findings suggest that pharmacologic inhibition of FTO could be a viable 
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Chapter 1 : Introduction and Literature Review 
1.1 Obesity 
According to the World Health Organization, more than 1 billion adults are 
overweight (body mass index (BMI)>25 kg/m2) and more than 300 million are 
obese (BMI>30 kg/m2); these numbers are expected to double by the year 
2025(3). Obesity represents a significant risk factor for mortality and many 
medical conditions including cardiovascular disease, stroke, hypertension; 
dyslipidemia, type 2 diabetes (T2D), osteoarthritis, asthma, non-alcoholic liver 
disease, gallstones and certain cancers(4). In Singapore, obesity is also 
reaching epidemic proportions in coincident with rapid nutritional and 
socioeconomic transition. The prevalence of obesity (BMI >30 kg/m2) had 
increased from 6.9% in 2004 to 10.8% in 2010. By BMI risk categories 
created for Asian populations including Singapore, 23.0% were in the high 
risk BMI category. Among the ethnic groups, Malays had the highest 
proportion of obese adults (24.0%) followed by Asian-Indians (16.9%) and 
Chinese (7.9%)(5). Despite the urgent need for therapeutic intervention, there 
is currently no safe and effective treatment for the disease. 
1.2 Causes of obesity 
The pathophysiology of obesity is characterized by a chronic energy 
imbalance between caloric intake and energy expenditure, however the 
relative contribution of inter-individual differences in energy intake and 
expenditure on this balance is unclear(6).  Positive energy balance occurs 
when excessive overfeeding relative to energy expenditure occurs, and the 
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body increases its overall energy stores.  Besides energy balance, 
macronutrient intake must also balance macronutrient oxidation. Even after 
controlling for energy balance and body fat, a positive association between  
24-h respiratory quotient (RQ)(high ratio of carbohydrate to fat oxidation) and 
weight gain was observed (7, 8). Higher carbohydrate oxidation can reduce 
glycogen stores and increase energy intake(9).  
1.3 Resting energy expenditure 
1.3.1 Definition 
Resting energy expenditure (REE) or basal/standard metabolic rate is the rate 
of energy utilized by an organism for basic cellular and organ functions (eg. 
muscle contract, heart beat, respiration) in fasting and resting state, and at 
thermoneutrality(10)(Figure 1.1) REE is the largest component of total energy 
expenditure (TEE) as it accounts for ≈ 65-70 % of TEE, therefore is a primary 
contributing factor to obesity. In addition, there is an increase in energy 
expenditure in response to food intake (thermic effect of food) which is heat 
produced during digestion, absorption, metabolism and storage of 
macronutrients. The thermic effect of food constitutes ≈ 10% of caloric 
content of meal ingested. Movement related or physical activity energy 
expenditure is energy expended by the skeletal muscle for any type of physical 
movement and is the most variable component of TEE(2). Apart from the 
three main components of energy expenditure, there is heat production in 
response to environmental temperature or diet (adaptive thermogenesis) such 
as cold-induced shivering thermogenesis in skeletal muscle, cold-induced non-
shivering thermogenesis in brown fat and diet-induced thermogenesis in 
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brown fat(11). Lastly, a small proportion is lost in the faeces and urine and a 




1.3.2 Low resting energy expenditure is a potential determinant of body 
weight gain 
The hypothesis that low REE is a predictor of weight gain is still 
controversial. Cross-sectional studies have shown that REE is higher in obese 
compared to nonobese subjects(12). When REE is normalized for fat-free 
mass (FFM), the metabolically active compartment, no difference is observed 
between obese and nonobese subjects(8) As body weight increases, REE rises 
towards a new equilibrium due to the increase in FFM to limit further body 
Figure 1.1 Components of total energy expenditure(2) 
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weight gain, which may play a confounding role in cross-sectional studies(13). 
Therefore, prospective and longitudinal studies represent the only ways to 
identify whether or not low REE is associated with body weight gain. Studies 
in adult nondiabetic Pima Indians have reported the inverse association 
between baseline REE and body weight gain. Ravussin et al reported that 
individuals within the lowest tertile of REE had an 8 fold greater risk of 
gaining 10 kg in body weight over a 4-year follow-up compared with those 
within the higher tertile of REE(14). The findings were subsequently 
confirmed in a separate group of Pima Indians, where weight change (-9 to 26 
kg) over 4 years of follow up was negatively associated with adjusted 
REE(15). In Caucasian Italians, Buscemi et al demonstrated that REE was 
significantly lower in subjects who gained weight (≥ 5kg) than in those who 
did not (108 ±2.1 vs. 122 ±3.1 kJ/kg-FFM, P<0.001)(16). In contrast, low 
REE was not found to be a predictor of body weight gain in other adult 
populations. Luke et al observed a positive association between weight change 
over 5.5 years of follow-up and REE adjusted for sex, age, body size and 
composition in lean Nigerian, suggesting that increased REE in this population 
was the result, rather than cause, of weight gain(17). No association between 
REE and weight change in Nigerian adults was observed(18). It remains to be 
observed whether the lower metabolic rates that have been observed in 
African-Americans will relate to subsequent weight gain. These studies may 
indicate that other factors such energy expenditure due to physical activity, 
energy intake or the change in energy balance over time and the ability to 
regulate body energy stores may be more important determinants of obesity 
rather than REE.   
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1.3.3 Determinants of resting energy expenditure 
Over the past decade, it has been shown that REE is determined by multiple 
factors including age(19), sex(20), ethnicity(21-23), body composition(24) 
and body fat distribution(25, 26). FFM remains the principal determinant of 
REE accounting for 50-70% of the variability in REE, being more 
metabolically active than fat mass(1, 27). However, it is argued that the close 
relationship between FFM and REE reported by many studies is artificial and 
attributed to the large heterogeneity of the subject population(28). Conversely, 
if the body weight or body composition of the subjects were relatively 
homogenous, the REE variability linked to body composition would tend to be 
low(29). An important problem arising from the use of FFM as metabolically 
active tissue surrogates is that the ratio of REE to FFM is not constant among 
individuals but varies systematically with body weight(30, 31). Specifically, 
individuals with smaller body mass and FFM tend to have higher REE: FFM 
ratios compared to heavier individuals, indicating higher energy production 
rates per unit of metabolically active tissue. Furthermore, when REE is 
regressed on FFM, a positive intercept (180-660 kcal/day) exists, implying 
that a significant component of REE remains even when FFM or body mass is 
extrapolated to zero(32) 
1.3.3.1 High metabolic rate organs and tissues 
Studies have demonstrated that a large proportion of inter-individual variation 
in REE can be explained by heterogeneity in the proportion of FFM as various 
organ and tissues(33, 34). FFM is a heterogeneous compartment, consisting of 
organs and tissues with large differences in the rates of energy flux. Compared 
with the resting metabolic rate of skeletal muscle (14.5 kcal/kg/d), the 
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metabolic rate of the brain is 18-fold higher (240 kcal/kg/d), of the heart and 
kidneys is 33-fold higher (440 kcal/kg/d), and of the liver is 15-fold higher 
(200 kcal/kg/d)(27). Gallagher et al demonstrated that high metabolic rate 
organs brain, liver, heart, kidneys and gastrointestinal tract account for a 
disproportionately large fraction of REE relative to their mass (Figure 1.2). 
They contribute 60–70% of REE in adults, whereas their combined weight is 
less than 6% of body weight(1). Among the high metabolic rate organs, liver 
constitutes 2% of body weight but contributes 17% of REE, brain constitutes 
2% of body weight but contributes 20% of REE, kidney constitutes 0.5% of 
body weight but contributes 6% of REE, heart constitutes 0.4% of body mass 
but contributes 11% and gastrointestinal tract constitutes 2% of body weight 
but contributes 10% of REE(10). In contrast, skeletal muscle tissue composes 
40–50% of total body weight but accounts for only 20–30% of REE. Adipose 
account for 15 % of body weight and contributes 4% of REE tissue even 
though they are metabolically less active(1).  
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1.3.3.2 Ethnicity  
Numerous studies have reported lower levels of REE, adjusted for body size 
and composition, in African-Americans than Whites (Table 1.1).  As a result 
of these findings, several investigators have suggested that a lower REE may 
be an important determinant of the higher prevalence of obesity observed in 
African-Americans than in Whites. Foster et al(35) and Jakicic et al(36) found 
a lower REE in obese African-American women than in obese white women. 
Sharp et al reported lower REE in African-American men than White men, in 
both lean and obese individuals(37). Tershakovec et al also reported that REE 
is lower in young African-American girls than White girls(38).  In contrast, 
there are studies demonstrating no significant differences in REE between 
African-Americans and Whites(39). Luke et al(40) also observed similar REE 
levels between African-Americans and Nigerians, two genetically related 
populations with dramatically different prevalence of overweight and obesity, 
casting doubt on the contributing role of REE to ethnic differences in obesity.  
Figure 1.2 Proportional contribution of organs and tissues to 
resting energy expenditure (REE) and fat-free mass (FFM) (1) 
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Table 1.1 Summary of studies that examined the impact of ethnicity on resting energy expenditure in relation to body weight and body 
composition. Studies are in chronological order.  
 
Weyer,1990
38 African American and 
288 white Respiratory chamber Hydrodensitometry
African Americans had lower REE than whites after 
adjustment for sex, age, and body composition, 
Nicklas, 1996
28 African-American and 
29 Caucasian women Indirect calorimetry DEXA
African American had similar REE to Caucasian 
women
Jakicic, 1998
41 women (22 African-
American and 19 
Caucasian)African-
American women Dilution technique DEXA
REE was lower in African-Americans compared to 
Caucasians, after adjustment for body weight and lean 
body mass
Soares, 1998
96 Indians and 81 
Caucasian Australians Indirect calorimetry Skinfolds
Absolute REE and REE adjusted for body weight were 
significantly lower in Indians when compared with 
Australians. However, REE adjusted for FFM, was not 
significantly different between the two groups.
Luke,1999
89 Nigerian  and 181 black 
adults Indirect calorimetry BIA
REE was not different between Nigerian and Black 
adults
Foster,1999
109 obese females (24
black, 85 white) Indirect calorimetry Densitometry
REE, adjusted for body composition, was lower in 
black than in white subjects
Hunter, 2000
18 African American and 




African American women had lower  REE than did the 
white women. Racial differences persisted after 
adjustment for limb lean tissue but disappeared after 
adjustment for trunk lean tissue
Measurement of REE
Measurement of 
body composition Main finding Subject characteristicsStudy
 
Abbreviations used: REE (resting energy expenditure), DEXA (dual energy X ray absorptiometry), BIA (bioelectrical impedence analysis), FFM (fat-free 
mass) 
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Table 1.1 Summary of studies that examined the impact of ethnicity on resting energy expenditure in relation to body weight and body 
composition. Studies are in chronological order. (continued) 
Sharp, 2001
100 African-American 
men, 95 white men, 94 
African-American women, 
and 106 white women Indirect calorimetry DEXA
REE was higher in white than in African-American 
individuals, even after adjustment for FFM, fat mass, 
visceral fat, and age. The difference was the same for 
men and women and for lean and obese individuals. 
Tershakovec, 2002
Obese children and 
adolescents. 66% were 
girls and 34% were 
African American. Indirect calorimetry DEXA
Adjustment for trunk lean tissue mass only partially
explains the lower REE of obese African American 
children and adolescents. 
Byrne, 2003
18 white and 22 black 
women Indirect calorimetry DEXA
REE adjusted for total LBM and fat mass, was  higher 
in white women 
Jones, 2004
22 pairs of age matched 
African American and 
white women Indirect calorimetry MRI and DEXA 
Lower REE in African-American women than in white 
women was fully explained by differences in the 
proportions of high metabolic rate organs
Gallagher, 2006
64 women (34 African 
Americans, 30 whites) and 
35 men (8 African 
Americans, 27 whites) Indirect calorimetry MRI and DEXA 
Racial differences in REE were reduced by 50% and
were no longer significant when the mass of specific 
high-metabolic rate organs was considered.
Wouters-Adriaens, 2010
10 white men, 10 Asian 
men, 10 white
women and 11 Asian 
women Indirect calorimetry Hydrodensitometry
Absolute REE was lower in Asians than in whites. 
There was no significant difference in REE between the 
two races after adjustment for FFM
Javed, 2010
55 women (30 African
Americans and 25 whites) 
and 32 men (8 African 
Americans and 24 whites) Indirect calorimetry MRI and DEXA 
Lower REE in African-Americans than Whites was 
fully explained by trunk high metabolic rate organs. 
Study  Subject characteristics Measurement of REE
Measurement of 
body composition Main finding
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1.3.3.3 Adipokines 
Adipose tissue is an active endocrine organ secreting adipokines such as leptin 
and adiponectin shown to play important roles in energy balance (41). 
Administration of recombinant leptin in leptin deficient ob/ob mice induced 
weight loss by decreasing food intake and increasing resting and physical 
energy expenditure(42-44). Kubota et al have showed that in mice, 
adiponectin activates AMP-activated protein kinase (AMPK) by 
adiponectin/adiponectin receptor (adipo-R1), which is associated with 
increased phosphorylation of acetyl-CoA carboxylase (ACC) in the 
hypothalamic ARC, leading to stimulation of food intake and reduction of 
energy expenditure(45). Several studies have reported positive(39) or 
negative(46) associations between circulating leptin levels and REE, whereas 
other studies have no association(47, 48) between leptin and REE. The effect 
of adiponectin in REE human studies is also controversial. Some studies(49, 
50) have shown negative associations between total adiponectin and REE even 
after adjustment for body composition while others have failed to replicate this 
result(51, 52). Discrepancies in findings may reflect inconsistencies in 
accounting for the confounding effect of fat mass on the relationship between 
leptin, adiponectin and REE.  
 
Recently, novel adipokines such as fibroblast growth factor 21 (FGF21) and 
apelin have been implicated in the regulation of body mass and whole body 
energy homeostasis. FGF21 is expressed in liver, white adipose tissue (WAT), 
skeletal muscle, and pancreas. Administration of FGF21 ameliorated obesity 
phenotypes in diet induced obese (DIO) and ob/ob mice by increasing oxygen 
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consumption, core body temperature, even though no decrease in total calorie 
intake or effect on physical activity were observed(53). Moreover, injection of 
FGF21 in neonates enhanced the expression of genes involved in 
thermogenesis within brown fat and increased body temperature(54). 
According to Holland et al, FGF21 is a potent regulator of adiponectin 
secretion and critically depends on adiponectin to exert its glycemic and 
energy metabolism effects. Lee et al recently reported that in humans, mild 
cold-induced increase in FGF21 was associated with cold induced 
thermogenesis independent of age, gender, fat mass, and lean mass(55). They 
went on further to show that FGF21 treatment enhanced brown fat 
thermogenesis in human adipocytes in a depot-specific manner(56). 
 
Apelin is a novel bioactive peptide discovered from bovine stomach extracts 
as an endogenous ligand of the G-protein-coupled 7-transmembrane receptor, 
APJ(57). Active forms of apelin are expressed in many peripheral tissues 
(heart, lung, kidney, liver, adipose tissue, gastrointestinal tract and 
endothelium) and different brain regions, particularly the hypothalamus(58, 
59). Studies in rodents suggest that apelin has functional roles in regulating 
energy metabolism. Higuichi et al reported that apelin attenuated body 
adiposity in normal and diet induced obese mice by increasing energy 
expenditure mediated by brown adipose tissue uncoupling protein 1 
(UCP1)(60). Dray et al demonstrated that apelin decreases glycemia by 
stimulating glucose uptake in skeletal muscle through an AMP-activated 
protein kinase (AMPK)-dependent pathway(61). In the study of Yamamoto et 
al, apelin stimulates energy expenditure by increasing vascular mass, aerobic 
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type-1 muscle fibre ratio and mitochondrial biogenesis in skeletal muscle(62).  
Emerging evidence has also shown that MCP-1 may promote chronic low-
grade inflammation through pro-inflammatory cytokines, increasing energy 
expenditure in a regulatory-feedback manner to prevent fat accumulation in 
obesity(63-67). MCP-1 is a key molecule that mediates infiltration of adipose 
tissue macrophages (ATM), the dominant source of production of pro-
inflammatory cytokines during adipose tissue expansion(68). A study have 
shown that mice overexpressing MCP1, exhibited an increase in energy 
expenditure and resistance to diet induced obesity(66) 
1.3.3.4 Skeletal muscle  
Variability in energy expenditure has been shown to be associated with 
variability in skeletal muscle metabolism (69, 70). Because of its relatively 
low resting energy metabolism, skeletal muscle has often been neglected when 
trying to explain inter-individual differences in REE.  Since skeletal muscle 
accounts for 40-50% of body weight in non-obese subjects, it can account for 
20-30% of total resting oxygen uptake (1, 71). Zurlo et al demonstrated that 
whole body REE normalized for age, sex, FFM and fat mass positively 
correlated with forearm resting oxygen uptake (69). Astrup et al showed that 
skeletal muscle is the principal site of thermogenesis, accounting for 40% of 
adrenaline-induced thermogenesis(70, 72). Several factors might influence the 
variation in muscle energy expenditure, including thyroid hormone, muscle 
tone, sympathetic innervation, catecholamine levels, and muscle fiber type 
composition Studies have also reported the association between REE and 
maximal activities of enzymes involved in energy-generating pathways (ie 
glycolysis, β-oxidation, tricarboxylic acid cycle, electron transport chain) such 
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as phosphofructokinase (PFK)(73), citrate synthase, cytochrome-c oxidase 
(COX) and 3-hydroxyacyl-CoA dehydrogenase (HADHA)(74).  
1.3.3.4.1 Mitochondrial energy metabolism 
The oxidation of fatty acids and pyruvate takes place in mitochondria where 
energy is converted into ATP for use in cellular processes (Figure 1.3). In the 
tricarboxylic acid (TCA) cycle, acetyl-CoA from fatty acid oxidation and 
glycolysis is oxidized to reduced coenzymes, nicotinamide adenine 
dinucleotide (NADH) and flavin adenine dinucleotide (FADH2), which 
deliver their electrons to the electron transport chain (ETC) located on the 
inner mitochondrial membrane. As electrons move down through the 
complexes of the ETC, energy is used by complexes I, III and IV to pump 
protons outside of the mitochondrial inner membrane, creating an 
electrochemical potential gradient. During oxidative phosphorylation, protons 
are driven back into the matrix through the F1Fo-ATP synthase and the 
potential energy in the proton motive force is used to drive conversion of ADP 
to ATP (11). If ADP is unavailable, protons are unable to enter through ATP 
synthase, causing the elevated electrochemical proton gradient to put 
backpressure on proton pumps in the ETC, inhibiting substrate oxidation and 
mitochondrial respiration (75). Hence, energy expenditure can be increased by 
increasing utilization of ATP, thus increasing availability of ADP or 
“uncoupling” of the tight relationship between fuel oxidation and ATP 
production, allowing fuels to be oxidized in the absence of ADP. Classically, 
two major biochemical systems are believed to contribute to energy 
expenditure: (1) futile cycles which increase utilization of ATP such as protein 
turnover, ion cycling across plasma membranes (Ca2+ ATPase) and 
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triglyceride-fatty acid substrate cycling and (2) mitochondrial proton leak(76).  
 
1.3.3.4.2 Contribution of ATP consuming reactions to REE 
 
Several ATP consuming reactions for energy dissipation are protein turnover, 
futile calcium cycling and triglyceride-fatty acid substrate cycling. Protein 
turnover, which is the degradation of proteins into amino acids and resynthesis 
of new proteins has been estimated to account for 15-20% of REE in humans 
(77). Most tissues exhibit protein turnover, especially the skeletal muscle 
tissue (25% of total protein turnover), skin (18%), liver (24%), and small 
intestine (15%)(77). Welle et al demonstrated in healthy young subjects that 
REE is highly correlated with leucine flux, an index of proteolysis and non-
oxidized portion of leucine flux, an index of protein synthesis(78). Conditions 
such as hyperthyroidism, diabetes, leukemia and overfeeding produce an 
Figure 1.3 Mitochondrial energy metabolism 
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increase in both REE and protein turnover, whereas under-nutrition reduces 
both REE and protein turnover. REE and protein turnover are also increased in 
patients with severe chronic obstructive pulmonary disease(79). In both short 
term and long term studies, high protein diets have shown to increase energy 
expenditure and improve body weight control(80, 81). After a fast in humans, 
whole-body nitrogen turnover and the thermic response to protein diet feeding 
were found to be significantly greater when compared with a high-
carbohydrate meal(82). 
  
Previous work has shown that Ca2+ adenosinetriphosphatases (ATPases) 
accounted for 20% of resting metabolic rate in adult rats(83, 84). The 
thermogenic potential of futile Ca2+ cycling is evident from the pathological 
syndrome of malignant hyperthermia, a dominant genetic disorder of humans 
due to a mutation in the skeletal muscle ryanodine receptor (Ryr), the calcium 
release channel of the sarcoplasmic reticulum. Abnormal Ca2+ release, 
triggered by anaesthesia or stress, causes intense thermogenesis, which leads 
to hyperthermia(85). Cold exposure in uncoupling protein 1(UCP1) deficient 
mice showed an increase in Serca2a (sarcoplasmic reticulum Ca2+ ATPase) 
expression, which enabled a calcium cycling induced rise in energy 
expenditure(86). In hyperthyroid patients and healthy controls, Ca2+ ATPase 
content in skeletal muscle correlated with REE(87).  
 
In triglyceride-fatty acid cycling, fatty acids are released during lipolysis and 
subsequently re-esterified rather than oxidized(88). It was reported in animal 
models that substrate cycling between de novo lipogenesis and lipid oxidation 
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is stimulated by leptin, causing an increase in energy expenditure(89, 90) It 
has also been shown in humans that mild-cold exposure increased fatty acid 
cycling together with energy expenditure (91). Recently, Mainieri and 
colleagues reported a role for skeletal muscle stearoyl-CoA desaturase 
1(SCD1) in thermogenesis by desaturating the products of de novo lipogenesis 
and diverting them away from mitochondrial oxidation, hence inhibiting 
substrate cycling between de novo lipogenesis and lipid oxidation, thereby 
leading to a state of suppressed thermogenesis(92). The triglyceride/fatty-acid 
cycling is also involved in the thermogenesis associated with burn 
injuries(93), cancer cachexia(94), and after exercise(95) 
1.3.3.4.3 Contribution of mitochondrial proton leak to REE 
According to Rolfe and colleagues, mitochondrial proton leak accounts for 
50% of oxygen consumption rate of perfused, resting skeletal muscle and 25% 
of oxygen consumption rate of isolated resting hepatocytes in rat(10). In vivo, 
it has been calculated that mitochondrial proton leak in skeletal muscle and 
liver alone could account for about 20-25 % of rat REE (96). In humans, 
mitochondrial proton leak dependent respiration in skeletal muscle was 
positively associated with cold induced adaptive thermogenesis(97). Obese 
subjects demonstrated decreased uncoupled respiration per mitochondrial 
volume compared to lean subjects (98). Diet-responsive subjects who 
experienced 43% greater weight loss than diet-resistant subjects were shown 
to have greater skeletal muscle mitochondrial proton leak dependent 
respiration, suggesting that differences in metabolic efficiency explain some 
of the variability in weight loss success(99). Hence skeletal muscle 
mitochondrial proton leak may be an important determinant of energy 
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expenditure in humans. It is postulated that protons return to the matrix 
through alternative leak pathways independent of F1Fo-ATP synthase. This 
proton leak reduces the proton gradient driving ATP formation and uncouples 
respiration from oxidative phosphorylation, releasing stored energy in the 
form of heat(100). Adenine nucleotide translocase (ANT) and uncoupling 
proteins (UCPs) localized on the inner mitochondrial membrane may be 
involved in proton conductance pathways of mitochondria, hence are likely 
candidates to underlie the physiological variability in REE in humans. UCP1, 
UCP2 and UCP3 cause nucleotide-sensitive proton leak when they are 
activated by fatty acids or alkenals derived from the peroxidation of 
membrane phospholipids(101). The primary function of ANT is to catalyze 
ADP/ATP exchange across the mitochondrial inner membrane. Under 
respiring conditions, ATP 4− generated by oxidative phosphorylation is 
exported to the cytosol for use in cellular activities while ADP 3− is imported 
into the mitochondrial matrix for ATP synthesis. ANT is also thought to have 
an intrinsic property of mediating proton leakage, to be a regulatory 
component of the mitochondrial permeability transition pore and to be 
involved in mitochondria-mediated apoptosis. ANT causes carboxyatractylate 
(CAT) sensitive proton leak when activated by fatty acids, AMP or 
alkenal(102). Brand and colleagues demonstrated that ANT accounts for 1/2 to 
2/3 of the basal proton conductance independent of its fatty-acid-dependent 
proton-leak functions (103). There are four different ANT isoforms in humans 
that have distinct tissue specific expression patterns. ANT1 is predominantly 
expressed in the mitochondria of heart and skeletal muscle tissue(104), ANT2 
is sparse or absent in differentiated tissues, but more abundant in certain 
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proliferating tissues, ANT3 is ubiquitously expressed and ANT4 is 
specifically expressed in the testis(105).  
1.3.3.4.4 Uncoupling proteins 
Uncoupling protein 1 (UCP1) is a mediator of proton leak in brown adipose 
tissue, which is responsible for nonshivering thermogenesis in newborn 
humans and in small mammals. UCP1 ablated mice are more susceptible to 
cold temperatures and to obesity when housed at thermoneutrality (106, 107) 
In humans, the relevance of UCP1 in adult humans has been controversial as 
UCP1 is exclusively expressed in BAT. Histological evidence has indicated 
that BAT is present, albeit in small amounts, in adults throughout life, 
however attempts to find functional BAT or utilize its thermogenic capacity 
for weight loss have been largely unsuccessful(108-111). Recently, 
homologues of UCP1 have been found that are abundant in other tissues than 
BAT. UCP2 and UCP3, which have an approximate 59% sequence homology 
to UCP1, have been shown to have uncoupling activity (112-114). UCP2 is 
widely expressed in skeletal muscle, fat, heart, placenta, lung, liver, kidneys 
and pancreas while UCP3 is predominantly expressed in skeletal muscle and 
brown adipose tissue(112, 113, 115). UCP3 gene knockout mice exhibit lower 
state 4 respiration(116). Walder and colleagues reported an association 
between polymorphisms in UCP2 and sleeping metabolic rate (SMR) and TEE 
In Pima Indians(117). Bouchard et al also demonstrated significant 
associations between UCP2 gene polymorphism and REE in Quebec 
population(118). Schrauwen further reported that in Pima Indians, UCP3 
mRNA expression was positively correlated with REE adjusted for fat-free 
mass and fat mass and negatively correlated with BMI(119). Recently, Kimm 
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et al identified a significant association between REE and C allele in the UCP3 
exon 5 variant in African American women, which suggested that the UCP3 
exon 5 variant may account for lower REE in African American compared to 
Caucasian women(120). 
 
However, unlike UCP1, the role of UCP2 and UCP3 in regulating proton leak 
and energy expenditure is a subject of controversy. There are reports that the 
expression of UCP2 and UCP3 mRNA increases with starvation, a state 
known to be associated with decreased energy expenditure(121, 122). 
Elevation of UCP3 by high fat diet did not change skeletal muscle 
mitochondrial efficiency in humans (measured as the rate of PCr resynthesis 
after exercise)(123). Animal studies have also shown alternative roles of 
UCP2 and UCP3 in fatty acid oxidation to prevent lipid induced oxidative 
mitochondrial damage and the reduction of proton gradient to reduce 
production of reactive oxygen species (ROS)(112, 113, 116, 124-126). In 
human studies, many failed to find significant associations between genetic 
polymorphisms and mRNA of UCP2, UCP3 and REE(110, 127-129). Hence 
the physiological roles of human UCP2 and UCP3 in mediating energy 
expenditure are still under debate.  
1.4 Metabolic flexibility  
Metabolic flexibility (MF) is defined as the capacity for the organism to match 
fuel oxidation to fuel availability. The inability to modify fuel oxidation in 
response to changes in nutrient availability has been implicated in the 
pathogenesis of obesity and insulin resistance. Lean healthy individuals use 
lipids as a main source of fuel during fasting conditions and they readily 
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switch to carbohydrate (CHO) oxidation under insulin stimulation. 
Conversely, the inflexible muscle of obese insulin resistant or type 2 diabetic 
(T2D) individual is characterized by lower fasting rates of lipid oxidation and 
impaired ability to suppress lipid oxidation and increase CHO oxidation in 
response to insulin(130). The impaired ability to augment lipid oxidation 
during fasting conditions is a key mechanism, leading to accretion of lipid 
metabolites such as triglyceride, ceramides, diacylglycerol (DAG) and long 
chain fatty acyl-CoA in the skeletal muscle, which impair insulin signaling 
and contribute to insulin resistance(131).  
 
Thus far in human studies, MF has been measured as the increase in 
respiratory quotient (RQ) from fasting to glucose/insulin-stimulated conditions 
during a euglycemic hyperinsulinemic clamp (EHC) or mixed meal challenge 
(Table 1.2). Many studies have reported that obese insulin resistant(132) and 
T2D subjects(133) exhibit elevated fasting RQ and blunted increase in RQ 
during a hyperinsulinemic clamp. Studies are still lacking to identify 
mechanisms linking MF during a clamp and insulin resistance. Insulin-
stimulated glucose disposal rate is reported to be the main determinant of RQ 
change during a clamp, explaining 50% of its variance. This metabolic 
inflexibility is mostly the consequence of impaired cellular glucose uptake 
rather than defective cellular glucose oxidation(134). Furthermore, after 
controlling for glucose disposal rate, no improvement in MF is observed after 
weight loss in T2D subjects(134, 135).  
 
Studies that have evaluated MF using mixed meal challenge have yielded 
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conflicting results. Corpeleijn reported that postprandial increase in forearm 
RQ was blunted in impaired glucose tolerant compared to control subjects 
after a high fat meal (136). In contrast, Helibronn et al observed that in 
response to a high CHO meal, individuals with a family history of T2D had a 
similar increase in RQ compared with control subjects(137). Studies also 
reported no difference in the change in 24-h RQ between lean and obese 
subjects after 3 days of overfeeding with a high CHO diet, suggesting similar 
MF between groups(138). In a study by Ukrocopva et al, subjects with or 
without a family history of T2D had a similar decrease in 24-h RQ after 3 days 
of high-fat diet(139).  
 
Although the effects of BMI and diabetes status on MF have been observed, 
contribution of ethnicity to MF has been less explored. To our knowledge, 
only two studies have reported the significant contribution of ethnicity to MF. 
Berk et al observed that obese Caucasian women had significantly higher fat 
oxidation and lower CHO oxidation during the high fat vs. low fat diet, 
whereas no significant differences in substrate oxidation were observed in 
African Americans. The African-American women also failed to suppress fat 
oxidation during pancreatic euglycemic clamp or increase fat oxidation in 
response to epinephrine infusion compared to Caucasian women(140). 
Impaired substrate switching in African-Americans may contribute to their 
greater prevalence of obesity and insulin resistance. In contrast, Stull et al 
reported greater substrate switching in African-Americans during a 
hyperinsulinemic euglycemic clamp compared to Caucasians, even after 
adjustment for insulin sensitivity(141).  
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Table 1.2 Summary of studies that examined metabolic flexibility during euglycemic hyperinsulinemic clamp (EHC) or mixed meal 
tolerance test (MMTT) 
Kelley, 1990
15 diabetic subjects was matched to 15 
nondiabetic subjects EHC
Insulin-stimulated leg glucose uptake in the diabetics did not differ 
from controls after matching for muscle glucose uptake
Kelley, 1990 Sixteen lean and 40 obese EHC
During fasting conditions, obese subjects had an elevated leg RQ. 
During insulin infusions, fat oxidation by leg tissues was
suppressed in lean but not obese subjects
Kelley, 1994
11 non-insulin-dependent diabetes
mellitus (NIDDM) and 9 nondiabetic 
subjects MMTT 
Postabsorptive leg RQ was increased in NIDDM. During 6 h after 
ingestion of a mixed meal, arterial free-fatty acid remained greater 
in NIDDM subjects
Goodpaster, 2003
9 men and 16 women completed
16 weeks of moderate-intensity physical 
activity combined with caloric reduction. Fasting Rates of fat oxidation following an overnight fast increased 
Blaak, 2006 701 obese and 113 lean MMTT ( 95% fat)
Postprandial fat oxidation decreased with increasing BMI. Fasting 
fat oxidation increased with increasing BMI.
Ukropcova, 2007
16 men with and 34 men without a family 
history of diabetes 3-day HFD
Subjects with a family history of diabetes had a significantly higher 
sleep RQ on the 3rd day of a HFD 
Galgani, 2008
59 type 2 diabetic and 42 nondiabetic
individuals matched for obesity, sex, and race EHC
Impaired metabolic flexibility to glucose observed in type 2 
diabetic versus nondiabetic subjects was no longer observed after 
adjusting for glucose disposal rate
Corpeleijn, 2008
Thirteen obese men with IGT and nine obese 
men with normal glucose tolerance (NGT), 
matched for age and BMI,
MMTT (33%  
carbohydrates, 
61% fat, 6% 
protein.)
The postprandial increase in RQ was blunted in IGT compared to 









168 human subjects of different races 
(55
African Americans, 113 Caucasians) EHC MF was higher in African Americans vs Caucasians
Huffman, 2011
46 men and 25 women randomized 
into control group ( healthy weight 
maintenance diet) and caloric 
restriction(CR) group MMTT
Larger differences in fasting-to-postprandial concentrations of 
medium and long chain acylcarnitines (byproducts of fatty acid 
oxidation) in the CR relative to control group
Weyer, 2011
14 male subjects( 7 Caucasians and 7 
Pima Indians)
48 h of mixed diet 
overfeeding and 
fasting 
Changes in 24-RQ in response to overfeeding and fasting were not 
different between Caucasians and Pima Indians
Study Subjects Assessment of MF Main outcome
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1.4.1 Role of mitochondrial function in metabolic flexibility  
Studies have indicated that mitochondrial abnormalities may be a primary 
cause of MF, however the causal link between the two remains to be 
established. Ukropcova et al reported that greater in vitro adaptability 
(increase in fat oxidation in the presence of high palmitate concentration) and 
lower in vitro suppressibility (glucose suppression of fat oxidation) correlated 
with higher metabolic flexibility and insulin sensitivity in healthy young 
males, thereby hypothesizing that metabolic switching is an intrinsic property 
of skeletal muscle(142). Myotubes established from patients with T2D exhibit 
reduced insulin-stimulated glucose uptake, oxidation, and glycogen synthesis, 
whereas palmitate exposure impaired insulin-stimulated glucose oxidation and 
insulin stimulated citrate synthase activity in control myotubes(143). Muscle 
mitochondrial content was higher in metabolically flexible subjects with high 
fat oxidation after a high fat diet (HFD) and contributed 49% of the variance, 
further supporting that metabolic switching from carbohydrate to fat oxidation 
is an intrinsic characteristic of skeletal muscles(139). Similarly, 
Chomentowski reported that intermyofibrillar mitochondrial content was 
significantly correlated with fasting RQ and MF(144). In response to high fat 
meal, subjects with a family history of T2DM had an impaired ability to 
increase fatty acid oxidation, which was associated with impaired activation of 
genes involved in lipid metabolism such as peroxisome proliferator-activated 
receptor coactivator-1(PGC1A) and fatty acid translocase (FAT/CD36)(137). 
Boyle and colleagues demonstrated that myotubes from lean subjects has 
increased mitochondrial respiration (state 3) in the presence of palmitoyl 
carnitine compared to obese subjects, indicating that skeletal muscle of obese 
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individuals inherently lacks metabolic inflexibility in response to lipid 
exposure(145). In contrast, some studies suggest that MF may not be a 
phenotype intrinsic to the skeletal muscle and a contributing factor to insulin 
resistance and T2D.  Gaster and colleagues reported that metabolic 
inflexibility in obese and diabetic patients is based on the inability to vary 
extracellular fatty acid concentrations during insulin stimulation(146). 
Similarly, Weijer reported that reduced mitochondrial function does not 
negatively impact the ability of skeletal muscle to switch substrates during 
insulin stimulation, rather it is primarily responsible for basal substrate 
oxidation. (147).  
1.5 Fat mass and obesity associated gene (FTO): first GWAS identified 
obesity gene 
Individuals respond differently to the “obesigenic” environment changes in 
diet and lifestyle and it is increasingly clear that variation in response has an 
important genetic element. Monozygotic and dizygotic twin studies have 
shown greater interpair than intrapair variation in weight loss, indicating that 
adiposity is highly heritable with the estimated genetic contribution of 40–
70% of the variance in weight gain(148, 149). Recognition of an important 
genetic influence on obesity has led to a search for causal genes which might 
help us fight this emerging epidemic. Genome wide association studies 
(GWAS) have identified at least 75 obesity susceptibility loci, including leptin 
(LEP), pro-opiomelanocortin (POMC), melanocortin 4 receptor (MC4R) and 
FTO (fat mass and obesity associated)(150). In the first GWAS study, single 
nucleotide polymorphisms (SNPs) in the first intron of FTO gene were found 
to be strongly linked with both BMI and T2D (151). However, the association 
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with T2D was abolished after adjustment for BMI, suggesting that the SNP 
predisposes to T2D through an effect on body weight. Of all GWAS-identified 
obesity susceptibility loci, the FTO gene has the most robust association with 
human obesity and greatest effect size(152). The minor risk allele increases 
BMI by 0.39 kg/m2 and risk of obesity by 1.20-folds(153). This genetic 
association was demonstrated across all age groups and in more than 22 
different ethnic populations including Chinese, Malay and Asian-Indian 
populations in Singapore(150, 154-156).  
 
A recent study showed that obesity associated FTO introns are functionally 
connected with the promoters of IRX3 rather than promoters of FTO through 
long range interactions. FTO SNP is associated with increased IRX3 
expression, and not with FTO expression in human brain. They further 
demonstrated that IRX3-knockout mice weigh about 30% less compared to 
wild types, primarily through loss of fat mass, increase in basal metabolic rate 
and browning of WAT(157). Although these findings with IRX3 are 
intriguing, they do not provide conclusive evidence against a contribution by 
FTO. Other lines of evidence that support a role for FTO in obesity comes 
from several animal studies where inactivation of FTO protein is found to 
protect from diet-induced obesity(158). In particular, FTO-/- and FTOI367F 
(mouse with a dominant missense I367F mutation in the FTO gene) mice were 
found to have significantly reduced adipose tissue, apparently due to an 
increase in energy expenditure and a decrease in lipogenesis(158, 159). All 
these results suggest that FTO is potentially the bonafide target of obesity. 
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1.6 Rationale of Study 
This study is novel in identifying the most accurate equation appropriate for 
predicting energy needs in the Singaporean Chinese population, which is 
important in establishing adequate dietary intake goals for effective weight 
management of overweight or obese individuals in obesity clinics, nutritional 
management of hospitalized patients to avoid the adverse effects of 
overfeeding and underfeeding and estimation of the energy requirements of a 
population. This area has considerable public health potential.  
 
In addition, this study is novel in examining differences in resting energy 
expenditure (REE) and fuel utilization among Chinese, Malays and Asian-
Indians in Singapore, which may be particularly important given that these, 
and related, populations, represent up to 2/3 of the world’s population. Most 
studies looking at ethnic variability in REE and fuel utilization were 
completed in North American populations and specifically focused on African 
American/Caucasian differences. An understanding of ethnic differences in 
these metabolic risk factors for obesity will facilitate the development of 
targeted and more efficacious interventions for the overweight individual 
based on ethnicity.   
Current approved clinical approaches for treatment of obesity such as energy 
restricted diets, increased physical activity and pharmacological treatments 
have limited impact. Current anti-obesity drugs aim to reduce food intake by 
either curbing appetite or suppressing the craving for food. Due to their central 
mode of action, they suffer from severe psychiatric and/or cardiovascular side 
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effects, many of which are withdrawn from the market as a result. Bariatric 
surgery, arguably the only effective treatment we have for obesity, is 
associated with serious risks and complications. While there is little doubt 
about the benefits of exercise and healthy diets in improving overall health, it 
is evident that additional approaches must be explored to improve the long-
term effectiveness of interventions. Losing weight by caloric restriction is not 
successful in the long term as weight loss causes a reduction in REE, which 
could be a risk factor for body weight gain, making further weight loss even 
more difficult(160). Structured exercise programs designed to increase TEE 
have only a low efficiency and have generated mixed results. The limited 
potency for physical activity to increase TEE may be due to the fact that the 
caloric cost per time unit of common exercise types are typically low 
compared to caloric intake. Hence targeting cellular energy expenditure 
(bioenergetics) via non-exercise means may be an attractive alternative 
approach. The molecular mechanisms underlying variability in energy 
metabolism and fuel utilization in human skeletal muscle are largely unknown.  
Proper characterization of these molecular mechanisms in human skeletal 
muscle is particularly important in the discovery and validation of therapeutic 
targets that might be useful and promising for the pharmacotherapy of obesity 
and its associated complications.  
 
In particular, FTO is an attractive therapeutic target for obesity and related 
metabolic diseases because it not only shows robust link with obesity in 
humans, the protective FTO allele is also not known to be associated with any 
adverse phenotypes. This potentially translates to a safer and more efficacious 
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approach to obesity treatment compared to conventional targets. Although 
there is compelling evidence that an increase in FTO expression underlies the 
obesity phenotype, the exact mechanism by which FTO regulates weight and 
energy homeostasis remains to be elucidated. It is, therefore, of clinical 
interest to understand the physiological functions and biological significance 
of FTO and explore its epigenetic link to obesity. Our research could pave the 
way for novel anti-obesity drugs that target the genetic causes of obesity.  
Overall, our study findings have potential public health, diagnostic, 
pharmaceutical and translational opportunities for targeted intervention and 
prevention of obesity. 
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1.7 Aims of Study 
This study aims to explore the impact of ethnicity on resting energy 
expenditure (REE) and fuel utilization in Chinese, Asian-Indian and Malay 
men and characterize the underlying mechanisms by which FTO (fat mass and 
obesity associated gene) regulates body weight and energy homeostasis. 
Specific aims of this study are to:  
 
1. Evaluate the validity of Food and Agriculture Organization/World 
Health Organization/United Nations University (FAO/WHO/UNU) 
equation and other commonly used prediction equations, Harris 
Benedict, Mifflin et al and Owen et al for REE in a sample of healthy 
Singaporean Chinese men.  
 
2. Determine whether ethnicity is associated with REE and the role of fat 
free mass (FFM), fat mass and mass/volume of high metabolic rate 
organs (represented by brain volume and trunk FFM) to these ethnic 
differences in REE. We further sought to examine whether inter-
individual variation in circulating concentrations of adipokines help to 
account for inter-individual variation in REE once the effects of FFM 
and fat mass had been accounted for.  
 
3. Determine whether metabolic flexibility is associated with ethnicity, 
obesity and insulin resistance in Chinese, Asian-Indian and Malay 
men. We further sought to understand any associations observed could 
be explained by plasma metabolic intermediates (acylcarnitines, 
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organic acids and amino acids) using metabolic profiling, and plasma 
levels of adipokines  
 
4. Determine whether potential inter-individual differences in skeletal 
muscle characteristics can explain variability in REE and MF and also 
the impact of ethnicity on molecular factors affecting skeletal muscle 
energy metabolism 
 
5. Characterize the function of FTO in skeletal muscle energy 
metabolism and substrate utilization and examine how the N6-
methyladenosine (m6A) demethylation activity of FTO contributes to 
its metabolic effects and obesity using two approaches a) genetic 
approach by gene silencing and b) chemical probe approach using a 











Chapter 2 : Materials and Methods 
2.1 Study Design 
The Singapore Adult Metabolism (SAM) study is a cross sectional study 
designed to investigate the contribution of ethnic, genomic and developmental 
factors to the variation in phenotype observed in adults with obesity and 
metabolic syndrome.  This study involves detailed phenotyping of adults that 
combines a variety of approaches including metabolic imaging, experimental 
physiology in humans and molecular biology using primary human myotubes 
as the in vitro experimental model. The study was granted ethical approval by 
the Domain Specific Review Board of the National Healthcare Group and 
written informed consent was obtained from each subject. We recruited 264 
healthy adult males, comprising 101 (38.3%) Chinese, 82 (30.7%) Malays and 
81 (31.1%) Asian-Indians. For screening, study subjects were required to fast 
overnight (10–12 hours). Following informed consent, baseline 
anthropometric measurements, complete medical history, physical 
examination and blood pressure (in mmHg) were recorded. Following 
screening, eligible subjects will enter the study. Subjects were recruited by 
advertisement. 
2.2 Eligibility 
2.2.1 Inclusion criteria 
Participants must meet all of the following to criteria to participate in this 
study 
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• Males aged 21-40 years. We have chosen to study men in order to 
avoid potential gender bias confounded by the menstrual cycle on 
metabolic parameters. However, it should be noted that this experiment 
reflects an initial proof of concept and we will later extend our studies 
to include pre menopausal women based on the findings of this initial 
study. The selection of a relatively young study population avoids 
potential confounding by other co-morbidities and drug treatment.  
• Body mass index (BMI) 18.5-30.0 kg/m2 .We defined lean individuals 
as BMI 18.5-22.9 kg/m2, overweight as BMI 23.0-27.4 kg/m2, and 
obese as BMI ≥ 27.5 kg/m2. This was in line with the WHO expert 
consultation in 2002 that in Asian populations, BMI 18.5-23.0 kg/m2 
represents increasing but acceptable risk, BMI above 23.0 kg/m2 
represents increased risk, and BMI above 27.5 kg/m2 represents high 
risk for cardiometabolic disease 
• Fasting plasma glucose below the threshold for diagnosing T2DM 
(<7.0 mmol/L) 
• Normotensive, defined as blood pressure <140/90 mmHg 
• Sedentary lifestyle defined as exercise <1 time/week of 30 minutes 
duration 
2.2.2 Exclusion criteria 
All subjects meeting any of the exclusion criteria at baseline will be excluded 
from participation. 
• Treatment for diabetes mellitus, hypertension and dyslipidemia in view 
of the nature of the study to examine the degree of physiological and 
metabolic derangements among an overtly healthy group, and being on 
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treatment would interfere with the interpretation of metabolic 
parameters. While we exclude participants who were already on 
treatment for hypertension, dyslipidemia or diabetes mellitus, those 
having the features suggesting metabolic syndrome (as defined by 
locally accepted guidelines, e.g. NCEP/MOH/WHO/AHA/ACC) but 
who were as yet untreated were also included as it was expected that a 
significant number of overweight and obese participants with the 
metabolic syndrome may be asymptomatic and thus appear overtly 
healthy 
• Use of medications that will likely affect energy expenditure (eg. 
sibutramine) and insulin resistance (eg. glucocorticoids, ACE-
inhibitors, protease inhibitors, metformin). Similarly, participants on 
an investigational drug in the past 6 months will be excluded as it 
would not be predictable if the agent has any effect on metabolic 
parameters.  
• Recent changes in body weight of >5% over the past 6 months or who 
were actively attempting to lose weight through dieting, bariatric 
surgery or anti obesity drugs were excluded in view of the need to 
recruit participants with stable weight of a given narrow distribution of 
BMI 
• Bleeding disorders which would preclude biopsies 
• Known allergy to insulin or local anaesthesia 
• Known allergy to milk or milk products ( eg. Ensure) 
• Presence of cardiac pacemaker or metallic clips, staples or stents in 
any part of the body which would preclude MRI/MRS 
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• Any serious illness requiring hospitalization or surgery in the past 6 
months 
• Use of any prescription medication that cannot be safely discontinued 
within 14 days prior to study entry 
2.3 Assessment of Anthropometry and Body Composition  
Demographic data, medical and drug history, and data on lifestyle factors were 
collected using interviewer-administered questionnaires. Body weight was 
measured in light clothing to the nearest 0.1 kg using an electronic scale 
(SECA, Vogel & Halke, Germany). Height was measured without shoes to the 
nearest 0.1cm using a wall-mounted stadiometer. BMI was calculated as 
weight divided by height squared (kg/m2). Whole body and regional (trunk, 
arms and legs) lean body mass (LBM), fat mass and bone mineral content 
(BMC) were measured by dual-energy x-ray absorptiometry (DEXA; Hologic 
Discovery Wi). BMC was used in the calculation of whole body fat percentage 
by the 4-compartment model(161). Fat-free mass (FFM) was calculated as the 
sum of LBM and BMC. Limb FFM was calculated by summing both arm and 
leg FFM. Limb FFM was used as an index of total skeletal muscle mass as 
suggested by Heymsfield et al (162) while trunk FFM was used as an index of 
visceral organ mass in the chest and abdomen (liver, kidneys, spleen and heart, 
gastrointestinal tract)(22). The coefficient of variation values for repeated 




2.4 Assessment of energy expenditure and respiratory quotient (RQ) 
On the test day, subjects reported to the National University Hospital at 0830 
h. They were instructed to transport themselves to the hospital in a vehicle to 
avoid undue exertion. They were required to undergo a 10 h overnight fast and 
refrain from intensive physical activity for 24 h prior to measurement. They 
were also advised to abstain from coffee and other nicotine containing food or 
beverage, heavy meals, and alcohol in the evening prior to measurement. 
Subjects were then allowed to lie supine quietly and relaxed for 15 min before 
measurement commenced. Measurements of oxygen consumption (VO2) and 
carbon dioxide production (VCO2) were performed by open-circuit indirect 
calorimetry using a ventilated hood system (Quark CPET, COSMED, Italy) 
for 1-hour in the fasting condition and continuously measured for a further 3-
hours following a mixed-meal tolerance test (MMTT). The MMTT was a 
standardized liquid meal (Ensure Plus®, Abbott Nutrition, Abbott 
Laboratories, Columbus, OH) with a total calorie content of 600kcal which 
comprised 55% from carbohydrates, 30% from fat (10% saturated fats, 10% 
polyunsaturated fats, 10% mono-unsaturated fat), and 15% from protein). A 
transparent Perspex ventilated hood was placed over the subject’s head, 
through which outside air was drawn by a pump. The flow rate (20—40 
L/min) was measured and adjusted to keep the difference in carbon dioxide 
readings between inspired and expired air within the range of 0.8—1.2%. A 
small sample of air leaving the hood was analyzed for oxygen (O2) and carbon 
dioxide (CO2) by a paramagnetic analyzer and infrared analyzer respectively. 
Calibration of flow and gas analyzers were done before each measurement 
according to the manufacturer’s instructions. Flow calibration was performed 
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by a 3-litre calibration syringe and gas analyzers were calibrated with dried 
standard gas mixture (16.01% O2, 4.98% CO2) and dried atmospheric air 
(20.93% O2, 0.03% CO2) The validity of the ventilated hood system was 
further tested by ethanol combustion tests conducted biweekly. The mean O2 
recovery was 98.8 ±1.9% (95% confidence interval 98.7 and 99.0) and the 
mean CO2 recovery was 98.3 ± 1.6% (95% confidence interval 98.2 and 98.4) 
(unpublished results). Correction factors were applied when necessary. All 
measurements were carried out in a quiet room with an ambient temperature 
of 23—25 ◦C, barometric pressure of 750—770 mmHg and constant humidity 
of 60%. During the measurements, subjects were lying in a semi-supine 
position, quiet, motionless and were kept awake by showing them non-
stressing movies, which were vetted for violent or sexual content that may 
excite them. To eliminate effects of subject habituation to the testing 
procedure, the respiratory measurements during the first 5 min were discarded. 
Only steady state periods of measurement of at least 30 min were used. REE 
was calculated from VO2 and VCO2 by the Weir formula(163). RQ was 
calculated from VO2 and VCO2 as follows: RQ=VCO2/VO2.  
2.5 Magnetic resonance spectroscopy (MRS) of liver and skeletal muscle 
adipose tissue 
Fat content in the liver and skeletal muscle were determined using 1H MRS 
using a 3 Tesla MR scanner (Tim Trio, Siemens)(164). The liver spectra were 
obtained from a 2Å~2Å~2cm3 voxel from two locations (right and left lobes) 
using a PRESS sequence (TE/TR = 30/2000ms) and a Siemens body matrix 
coil. The acquired spectra were fitted using the linear combination of model 
spectra (LCModel). The liver fat was determined from the concentration of 
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methyl and methylene groups of lipids and unsuppressed water signal. The fat 
concentration obtained was corrected for T2 losses and was also verified by 
region-of-interest analysis with Dixon imaging. For skeletal muscle 
spectroscopy, the subjects' right leg was positioned in a leg holder and the foot 
was aligned to eliminate residual dipolar interactions. The muscle spectrum 
was obtained from a 2Å~2Å~2cm3voxel within the soleus muscle using a 
PRESS sequence (TE/TR = 30/2000ms) and a Siemens Tx/Rx 15-Channel 
Knee Coil. The amount of IMCL was calculated and expressed as a ratio to 
Creatine (Cr), i.e. IMCL/Cr. 
2.6 Magnetic resonance imaging of abdomen 
Abdominal fat images were acquired using two 2-point DIXON sequences 
(TR=5.28ms, TE1=2.45ms, TE2=3.68ms, FA=9deg, slice thickness=3mm) 
during breath-holds of 18–20 seconds. Fat volume in each abdominal fat 
compartment was obtained from 80 axial slices covering the L1 to L5 lumbar 
vertebrae. A fully automatic graph theoretic segmentation algorithm extracted 
and estimated the subcutaneous (SAT) and visceral (VAT) adipose tissue 
volumes. The segmentation algorithm was a two-step process. First, the fat 
tissues were separated from the non-fat tissues by thresholding. The extracted 
fat tissues were then classified into SAT and VAT using a graph cut technique 
which has been validated on the skull stripping problem(165). The segmented 
image volumes of each of the fat depots were quantified by adding all the 
voxels of all the slices and multiplying by the image resolution. This method 
provides valid estimates of fat volume compared to manual segmentation with 
Dice similarity index ranging from 0.7-0.89 (where 0 indicates no overlap 
between the 2 methods and 1 indicates perfect overlap). 
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2.7 Magnetic resonance imaging of brain  
High-resolution images of the brain were acquired using a T1- weighted MP–
RAGE sequence. There were 192 contiguous sagittal slices with the following 
scanning parameters: TR=2530 ms, TI=1200 ms, flip angle=7˚, FOV 
256mm×256 mm, 256×256 matrix, isotropic voxel dimensions of 1.0mm, 
6min 3s acquisition time. Automated measurements of brain volumes were 
performed using FreeSurfer 4.5.0 (http://surfer.nmr.mgh.harvard.edu/). Total 
brain volume was calculated as sum of total cerebral gray matter, cerebral 
white matter, brain stem and cerebellum(149) Estimated total intracranial 
volume (eTIV) calculated using a method described by Buckner et al was used 
as a covariate(166).  
2.8 Hyperinsulinemic euglycemic glucose clamp 
Insulin sensitivity was assessed after a 10hr overnight fast using the 
hyperinsulinemic euglycaemic clamp technique. Insulin was infused at a 
fixed-rate of 40 mU/m2 body surface area/minute for the duration of the clamp 
(90min) in order to achieve a plateau (steady-state) insulin level about 100 
µU/mL above basal concentration. Blood glucose level was measured every 
5min using the glucose oxidase method (Yellow Spring glucose analyzer, 
Ohio, USA). The infusion rate of the 20% dextrose solution was adjusted to 
maintain a constant blood glucose level at approximately 90mg/dL (5mmol/L) 
throughout the clamp. Under these conditions, hepatic glucose production will 
be totally suppressed. Insulin sensitivity index (ISI) (M/I) was calculated using 
the mean glucose infusion rate (M) and steady state insulin concentration (I) 
during the final 30min of the clamp(167).  
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2.9 Biochemical analyses 
Venous blood samples were drawn from all subjects in the morning after a 10-
hour overnight fast. Blood samples were collected according to 
recommendations of the individual assay kits’ manufacturers. Serum and 
plasma samples were frozen and stored at -80°C until the tests were 
performed. Serum insulin was measured using a chemiluminescence assay 
(ADVIA Centaur analyzer, Siemens Healthcare Diagnostics). Plasma glucose 
was measured using an automated analyzer (ADVIA 2400; Bayer Diagnostics, 
New York, USA).  
2.10 Enzyme-linked immunosorbent assay (ELISA) 
Plasma and serum levels of adipokines were determined by enzyme-linked 
immunosorbent assay (ELISA). Serum leptin, fibroblast growth factor 21 
(FGF21), resistin, monocyte chemoattractant protein 1 (MCP1) and rentinol 
binding protein 4 (RBP4) levels were measured using ELISA kits(Millipore, 
Billerica, MA). Plasma total adiponectin was measured by adiponectin 
(multimeric) ELISA kit (Alpco Diagnostics, Salem). Serum apelin levels were 
determined by ELISA kit(Human Apelin ELISA kit Phoenix Pharmaceuticals, 
Belmont, CA).  Protocol was as follows: Add 50 ml/well of standard, sample, 
or positive control, 25 ml primary antibody and 25 ml biotinylated peptide. 
Incubate at room temperature for 2 hours. Wash immunoplate 4 times with 
350 ml/well of 16assay buffer. Add 100 ml/well of streptavidin-horseradish 
peroxidase (SA-HRP) solution and incubate at room temperature for 1 hour. 
Wash immunoplate 4 times with 350 ml/well of 16assay buffer. Add 100 
ml/well of Tetramethylbenzidine (TMB) substrate solution and incubate at 
room temperature for 1 hour. Terminate reaction with 100 ml/well of  HCI. 
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Read absorbance OD at 450 nm and calculate results.  
2.11 Muscle Biopsies 
Percutaneous muscle biopsy was obtained from the vastus lateralis under local 
anaesthesia in individuals who provide informed consent for this procedure. 
One specimen was aliquoted immediately into phosphate buffered saline 
(PBS) for myoblast cultures. The other samples will be frozen in liquid 
nitrogen and stored at -80 °C. Muscle tissue was minced and digested with 
0.2% collagenase type 1A (C5894; Sigma-Aldrich, St. Louis, USA) for 90 
minutes at room temperature with shaking at 750 rpm, after which the cultures 
were pelleted down and passed through the 100 µm filter to remove 
undigested tissue. The cells were then re-suspended in Dulbecco’s modified 
Eagle’s medium (DMEM), supplemented with 20% fetal bovine serum (FBS, 
Invitrogen, Carlsbad, USA), 10% horse serum (HS) (Invitrogen), 1% 
penicillin-streptomycin (PS) (Invitrogen) and 1% chick embryo extract 
(C3999; US Biologicals, USA) and enriched for myoblasts by pre-plating on 
uncoated plates for 3hrs. After 3 hours of attachment, the supernatant having 
cells were preplated on to matrigel (Becton Dickinson)-coated plates and 
myoblast cultures were maintained at 37°C and 5% CO2. Upon reaching 90% 
confluency, primary myoblasts will be induced to differentiate in DMEM 
supplemented with 2% HS and 1% PS for 7 days prior to experimentation. 




2.12 Mitochondrial respiration 
Mitochondrial bioenergetics was measured in primary human myotubes ex 
vivo using a Seahorse XF24 Analyzer (Seahorse Biosciences, North Billerica, 
MA). Myoblasts were seeded on XF24 tissue culture plates at 20 000 
cells/well in growth medium. Differentiation of myoblasts into myotubes was 
initiated at approximately 90% confluence, by switching to low-serum 
differentiation media containing DMEM, 2% HS and 1% PS. Myotubes were 
studied after 7 days of differentiation when myoblasts had fused to form 
multinuclear elongated myotubes. On the day of the assay, myotubes were 
then incubated for 45 min at 37°C at ambient CO2 in XF Assay Medium 
(Seahorse Biosciences) (pH 7.4) containing 4 mM glutamine, 1 mM pyruvate 
and 25 mM glucose. Oxygen consumption rate (OCR) was measured by 
monitoring the concentrations of dissolved oxygen by the XF24 Analyzer 
solid-state sensor probes above the cell monolayer. Baseline OCR (OCR 
Baseline) was measured 3 times for 4 min each separated by a 2 min wait and a 
2 min mix. Following the measurement of basal respiration, oligomycin (1uM) 
(Sigma–Aldrich, Oakville, ON, Canada) was injected into each well, followed 
by 3 cycles of: 2 min mix, 2 min wait and 4 min measurement to measure 
proton leak dependent respiration (OCR
 oligomycin). Oligomycin inhibits ATP 
synthesis by blocking the proton channel of the Fo portion ATP synthase, 
resulting in protons returning to the matrix through leak pathways, therefore 
measuring the proportion of oxygen used for ATP turnover and proton leak. 
Next, a mitochondrial inner membrane uncoupler, carbonyl cyanide p-trifluoro 
methoxyphenylhydrazone (FCCP) (0.8 mM) (Sigma–Aldrich, Oakville, ON, 
Canada) was injected into each well, followed by 3 cycles of: 2 min mix, 2 
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min wait and 2.5 min measurement to measure maximal respiration (OCR 
FCCP). FCCP produces a collapse in the proton gradient across the 
mitochondrial inner membrane, hence measuring the capacity of the electron 
transport chain (ETC). Finally, a mixture of rotenone (1 µM) and antimycin A 
(1µM) that blocks respiratory chain complexes I and III, was injected into 
each well, followed by 3 cycles of: 2 min mix, 2 min wait and 3 min 
measurement to measure non-mitochondrial respiration (OCR R/A). Parameters 
of mitochondrial bioenergetics were calculated as follows: 1) Basal OCR = 
OCR Baseline – OCR R/A, 2) ATP turnover = OCR Baseline - OCR Oligomycin , 3) 
Proton leak = OCR Oligomycin  – OCR R/A,  4) Maximal respiration = OCR FCCP 
– OCR R/A, 5) spare respiratory capacity = OCR FCCP – OCR Baseline (Figure 
2.1) and 6) Non-mitochondrial respiration (OCR R/A ). A total of 6 technical 
replicates were performed for each subject.  
 
The strength of measuring mitochondrial function in intact muscle fibers as 
opposed to isolated mitochondria is the greater physiological relevance. In 
intact cells, mitochondrial structure and membrane are intact, interactions 
between mitochondria and rest of the cell are preserved and mitochondria are 
exposed to a relevant mix of substrates and ions(168). In contrast, isolated 
mitochondria in vitro are typically exposed to non-physiological conditions. 
First, isolated mitochondria in vitro are exposed to oxygen concentrations that 
are much higher than what is present in cellular microenvironment in vivo. 
Furthermore, respiration and ATP synthesis rates are measured in response to 
substrate and ADP concentrations that are saturating and dramatically exceed 
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levels that are endogenous to the cell(169). The disadvantages however are 
that the mitochondria are not directly accessible to the full range of substrates 
and inhibitors, and the complexity of cytoplasmic metabolism must be 
considered together with the presence of separate pools of adenine 




2.13 Quantification of mRNA 
2.13.1 Total RNA isolation 
 
Total RNA was extracted from myotube cultures with RNeasy plus mini kit 
(Qiagen). Briefly, 600 µl of Buffer RLT Plus and 6 µl of β-mercaptoethanol 
(β-ME) was added to the 10 cm cell-culture dish. Lysate was homogenized by 
vortexing for 1 min. Lysate was pipetted directly into a QIAshredder spin 
Figure 2.1 Mitochondrial bioenergetics profile 
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column and centrifuged. The homogenized lysate was transferred to a gDNA 
Eliminator spin column and centrifuged. 600 µl of 70% ethanol was added to 
the flow-through which was transferred to an RNeasy spin column. The 
column was washed with buffers and RNA was eluted out in 30 µl of RNase-
free water.  
2.13.2 Reverse transcription (RT) 
cDNAs were synthesized from 1 µg of total RNA in a 20 µl volume using 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 2 X 
RT master mix reaction was prepared with the following components and 
mixed with 10 µl of RNA sample.  
 
10 X RT Buffer 2.0 µl 
25 X dNTP Mix (100 mM) 0.8 µl 
10 X RT Random Primers 2.0 µl 
MultiScribe Reverse Transcriptase 1.0 µl 
RNase free water 4.2 µl 
 
RT was then performed with the following conditions: 10 min at 25 °C, 120 
min at 37°C and 5 min at 85 °C. cDNA was diluted to 100 µl final volume and 
used immediately or stored at -20 °C.  
2.13.3 Quantitative real-time PCR (RT-PCR) 
RT-PCR reactions were performed in duplicates for each sample in a total 
reaction volume of 10 ul with the following components.  
 
 46
2 X Quantifast SYBR Green PCR Master Mix (Qiagen) 5 µl 
Forward primer (10 µM) 1 µl 
Reverse primer (10 µM) 1 µl 
RNase-free water 1 µl 
cDNA (10 ng/µl) 2 µl 
 
The reaction conditions were 5 min at 95°C for the initial heat activation step, 
followed by 40 cycles of 10 s denaturation at 95°C and 30 s annealing and 
extension at 60 °C. Dissociation curves were performed at the end of all runs 
to ensure specificity of primers. The relative expressions of respective genes 
were normalized to GAPDH and calculated using the comparative Ct 
quantitation method (2^ -ddCT). All primers were designed to span two 
consecutive exons to avoid co-amplification of genomic DNA, which may 
contaminate the RNA preparation. The complete list of primers is listed in 
Table 2.1. Reactions were performed using a Prism 7000 Sequence.  
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Table 2.1 List of primers used for real time PCR detection of gene 
expression in primary human myotubes. 
 


















































2.14 Quantification of protein 
2.14.1 Protein lysate preparation 
 
Cell cultures were lysed with RIPA buffer with cocktail of protease inhibitor, 
phosphatase inhibitor and EDTA (Pierce).  
2.14.2 Protein concentration determination 
 
Protein concentrations were determined using the Bio-rad Bradford protein 
assay. Briefly, eight serial dilutions of a standard BSA solution were prepared, 
starting with 1.0 mg/ml. 10 µl of the BSA standards and protein samples were 
added into the wells of a 96-well microtiter plate. The dye reagent was diluted 
(1 part Dye reagent concentrate with 4 parts distilled water) and filtered 
through 0.45 µM filter. 200 µl of the dye was then added to each well and 
incubated at room temperature for 5 min. Absorbance was measured at 595 
nm. The standard curve was constructed by plotting the known BSA 
concentration. Protein concentrations were determined by comparison with the 
BSA standard curve.  
2.14.3 SDS-PAGE separation of protein 
Typically, 10-25 ug of protein samples were run per well and were mixed with 
5X Laemmli buffer and β-mercaptoethanol. The samples were denatured by 
boiling for 10 min at 95°C before loading into the wells of 10% SDS-PAGE 
gel. The gel was run in 1 X SDS/Glycine buffer (25 mM Tris, 250 mM 
glycine, 0.1% SDS, pH 3) at 100 V until the dye front is approximately at the 
bottom of the gel.  
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2.13.4 Western Blot 
Proteins resolved by SDS-PAGE were transferred to PVDF membranes (Bio-
Rad). The membranes were then blocked in 5.0 % milk in PBST (10 mM Tris 
HCl, 100 mM NaCl, 0.02% Tween 20) and incubated with appropriate 
primary antibodies overnight at 4ºC with shaking. Primary antibodies used 
were FTO (Abcam, ab92821), phospho-Akt (Ser473) (Santa Cruz), UCP3 
(Abcam, ab3477), ANT1 (Santz Cruz, sc-11433), COX IV (Cell Signalling, 
4844), citrate synthase (Santa Cruz, sc-390693) with GAPDH (Cell 
Signalling) as a loading control. Membranes were washed with PBST and 
incubated with either anti-rabbit IgG Horseradish Peroxidase (HRP) conjugate 
(Bio-Rad) or anti-mouse IgG HRP conjugate (Bio-Rad) for 1 h at room 
temperature. Primary and secondary antibodies incubations were done in 
blocking buffer. The HRP activity was detected using Western Lightning 
Chemiluminescence Reagent Plus (NEL104; PerkinElmer Life Sciences, 
Wellesley, MA) and exposure to autoradiography film. Blots were quantified 
by densitometric analyses using Image J.  
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2.13.5 Medias and Buffers 
1 X PBS, pH 7.4 (Invitrogen, Singapore) 
• KH2PO4 (1.76 mM) 
• Na2HPO4 (10.4 mM) 
• NaCl (137 mM) 
• KCl (2.7 mM) 
Tris-buffered saline 
• Tris-HCL, pH 7.5 (50 mM) 
• NaCl (150 mM) 
5 X Reducing Laemmli buffer (Biorad, Singapore) 
• Tris-HCL, pH 6.8 250 mM 
• Glycerol 50% (v/v) 
• SDS 10% (w/v) 
• Bromphenol blue 0.05% (w/v) 
• Β-mercaptoethanol (0.5 ml in 10 ml of sample loading buffer) 
10X SDS-PAGE electrophoresis buffer 
• Tris base 250 mM 
• Glycine 2.5 M 
• SDS 1% (w/v) 
SDS-PAGE stacking gel 
• dH20 (3.05 ml) 
• 0.5 M Tris-HCL, pH 6.8 (1.25 mL) 
• 10% (w/v) SDS (50 µl) 
• 30% Acrylamide/Bis solution 29:1 (3.3%) (0.65 ml) 
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• 10% APS (25 µl) 
• TEMED (5 µl) 
SDS-PAGE separating gel (10%) 
• dH20 (3.17 ml) 
• 1.5 M Tris-HCL, pH 8.8 (2.5 mL) 
• 10% (w/v) SDS (100 µl) 
• 30% Acrylamide/Bis solution 29:1 (3.3%) (4.16 ml) 
• 10% APS (50 µl) 
• TEMED (5 µl) 
10X Western Blot transfer buffer 
• Tris base 25 mM 
• Glycine 192 mM 
• Methanol 15% (w/v) 
PBST buffer 
• 1 X PBS buffer with 0.05 % Tween 20 
Blocking buffer 







Chapter 3 : Validation of prediction equations for resting energy 
expenditure in Singaporean Chinese men 
3.1 Introduction 
The accurate determination of total energy expenditure (TEE) is important for 
establishing dietary intake goals in weight management of both normal weight 
and obese individuals and nutritional management of hospitalized patients to 
avoid the adverse effects of overfeeding and underfeeding. It is also used in 
estimating the energy requirements of a population. Since the routine use of 
indirect calorimetry (the criterion standard for measuring REE) is not feasible 
in daily clinical practice, predictive equations are often used to estimate 
REE(6). The validity of any predictive equation is crucial as REE is often used 
as the predictor of TEE as it accounts for 60-70% of TEE for people leading a 
sedentary lifestyle(8). Any bias in REE assessment would be amplified when 
it is multiplied by the factor that is used to estimate the TEE of a population or 
individuals. The Food and Agriculture Organization/World Health 
Organization/United Nations University (FAO/WHO/UNU) 1985 predictive 
equation developed using data from Schofield and colleagues have been 
adopted as a basic reference for the development of energy requirements in 
Singapore(77). However, it is unclear whether this equation can be applied 
successfully to the Singaporean population. The FAO/WHO/UNU equations, 
developed using predominantly European subjects, seemed to be less accurate 
in predicting REE in Asian populations(131, 170). In a study by Ismail et al., 
FAO/WHO/UNU equations overestimated the REE of adult Malays, Chinese, 
Indians and Dayaks living in Malaysia by 13% in male and 9% in female 
subjects(171) Recently, Tseng et al. reported that the measured REE was 
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significantly lower than REE calculated by the equation by 271 ± 311 kcal/day 
in Chinese subjects living in Taiwan(172). Researchers have also queried the 
continued applicability of the FAO/WHO/UNU equations in our modern 
population, with changes in body size and composition, physical activity level 
and diet (2). Several studies have shown that these predictive equations 
overestimated REE in Caucasian as well as in Asian populations(18, 173). 
Muller et al. reported that the WHO equations overestimated REE from the 
measured values by up to 14.3% in males and 7.5% in females in 
Germany(18). According to Piers et al., measured REE of Australian men and 
women were significantly lower than the predicted REE using 
FAO/WHO/UNU equations by 406 ± 513 kJ/day and 124 ± 348 kJ/day 
respectively(174). No validation studies on prediction equations for REE have 
been conducted in Singapore. Therefore, it is crucial to identify the most 
accurate equation appropriate for predicting energy needs in this population. 
The objective of this study was to evaluate the validity of FAO/WHO/UNU 
equation and other commonly used prediction equations, Harris Benedict, 
Mifflin et al and Owen et al from the literature in a sample of healthy 
Singaporean Chinese men.  
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3.2. Materials and Methods 
3.2.1 Subjects 
A total of 96 healthy Singaporean Chinese men participated in this cross-
sectional study. Inclusion and exclusion criteria of subjects were described in 
Section 2.2.  
 
3.2.2 Anthropometry 
Body weight and height was measured as described in section 2.3 BMI was 
calculated as weight divided by height squared (kg/m2). 
3.2.3 Measurement of resting energy expenditure 
REE was measured continuously by open-circuit indirect calorimetry using a 
ventilated hood system (Quark CPET, COSMED, Italy) for 60 min as 
described in Section 2.4. REE was calculated from VO2 and VCO2 by the 
Weir formula(163). In addition to measured values, REE was predicted by the 
FAO/WHO/UNU, Harris-Benedict, Owen et al and Mifflin et al equations 
(Table 3.1).  
 




Mifflin St Jeor (1990) REE=10*Weight +6.25*Height -5*Age +5
18-29 yr: REE= 15.3*W +  679
30-59 yr: REE=  11.6*W + 879FAO/WHO/UNU (1985)
REE= 66.473+ 13.7516*Weight 
+5.0033*Height -6.755*Age
REE= resting energy expenditure in kcal/day.  All equations use weight in 




3.2.4 Statistical Analyses 
Statistical analyses were performed using IBM SPSS Statistics for Windows, 
Version 20(175). Pearson’s correlation coefficients were used to examine the 
association between measured and predicted REE for each of the predictive 
equations. Measured and predicted REE were compared at a group level using 
student’s paired t test. Individual prediction accuracy was defined as the 
percentage of subjects that had an REE predicted within ±10% of REE 
measured(176). A prediction below 90% of REE measured was classified as 
under-prediction and a prediction above 110% of REE measured was 
classified as over-prediction(177). Bland and Altman plots (178) were used to 
determine agreement both graphically and numerically between measured 
REE and predicted REE by calculating mean bias (difference between 
measured and predicted REE) and limits of agreement (mean bias ± 2 SD). 
For good agreement, it is expected that bias will be close to zero, clinically 
acceptable limits of agreement that are within ±10% of measured REE and 
that there is no clear evidence of a relationship between difference and mean 
of measured and predicted REE Values are given as Mean ± SD The threshold 




3.3.1 Subject characteristics 
 
We studied 96 Chinese men with mean age of 28.4±6.0 years, weight of 
69.4±10.3 kg, height of 172±5.8 cm and BMI of 23.4±2.9 kg/m2.  
3.3.2 Mean differences and correlations between measured and predicted 
resting energy expenditure 
Significant correlations were found between measured REE and REE derived 
from the FAO/WHO/UNU equation(R = 0.68), Harris-Benedict equation (R = 
0.71), Mifflin equation (R = 0.70) and Owen equation(R = 0.67) (Table 3.2). 
However, the FAO/WHO/UNU, Harris-Benedict and Mifflin equations 
significantly overestimated mean measured REE by 120 ± 140 kcal/day, 96 ± 
137 kcal/day and 38 ± 136 kcal/day respectively. The Owen equation did not 
show a significant mean bias in the prediction of REE.  
 
Table 3.2 Differences and Pearson correlation coefficients between 
measured and predicted resting energy expenditure 
Mean S.D Mean S.D Lower Upper
Measured 1594 191
FAO/WHO/UNU 1714 137   120* 140 91 148 0.679*  -161 to 400
Harris Benedict 1689 158 96* 137 68 123 0.705*  -179 to 371
Mifflin 1632 126  38* 136 11 66 0.700*  -235 to 311
Owen 1587 105  -7 NS 144 -36 22 0.666*  -295 to 281
*P<0.05
NS, not significant






3.3.3 Bland Altman analyses 
The individual differences between measured and predicted values of REE 
plotted against the average of measured and predicted values are shown in 
Figure 3.1. The limits of agreement were wide for all equations. The 
individual differences between measured and predicted REE ranged from 







Figure 3.1 Bland Altman plots for comparison of agreement between resting 
energy expenditure measured by indirect calorimetry and predicted resting 
energy expenditure derived from prediction equations. 
 58
3.3.4 Percentage of accurate predictions, under-predictions and over-
predictions 
Focusing on the distribution of individual measured REE values revealed that 
Mifflin equation had the highest percentage REE predictive accuracy, with 
75% of the subjects falling within ±10% of measured REE followed by the 
Owen equation with an individual prediction accuracy of 73% (Table 3.3). 
Compared to the Mifflin equation that more commonly overestimated REE 
than underestimated it, the Owen equation had similar numbers in which REE 
was over- or underestimated. REE could not be accurately predicted by the 
FAO/WHO/UNU and Harris-Benedict equations in more than 30% of the 
subjects. 
 
Table 3.3 Percentage of subjects with accurate predictions, under-
predictions and over-predictions. 
Equation
FAO/WHO/UNU 60.4 1 38.5
Harris Benedict 66.7 1 32.3
Mifflin 75 5.2 19.8
Owen 72.9 14.6 12.5
Accurate 







In our study, the measured REE was significantly lower than that predicted by 
the FAO/WHO/UNU, Harris-Benedict and Mifflin equations by 7.5%, 6.0% 
and 2.4% respectively, in a group of adult Singaporean Chinese men. 
However, the Owen equation provided valid estimates of REE with only slight 
underestimation (0.4%). Several researchers have also reported overestimation 
of REE in Asians using FAO/WHO/UNU and Harris-Benedict equations, and 
found percentage differences comparable to those of our study(8). According 
to Nhung et al, predicted values using the FAO/WHO/UNU equations were 
significantly higher than measured REE by 8.5% and 5.4% respectively in 
Asian subjects(6). In a study by Liu et al, the Harris Benedict equation over-
predicted measured REE by 8% in Chinese. On the other hand, the Liu 
equation that was derived from Chinese adults, predicted the REE of Asians 
more accurately(77). These are similar to the 7.5% (FAO/WHO/UNU 
equation) and 6.0% (Harris Benedict equation) observed in our study. It has 
been suggested that such overestimation of REE by these prediction equations 
in Singaporean Chinese may be largely explained by ethnic differences in 
REE related to body composition(86, 131, 179). The Schofield database was 
dominated by Italian data that constituted 3388 out of a total of 7173 REE data 
points(164, 170). Hayter and Henry further reported that Italian subjects had a 
higher REE per kilogram of body weight compared to other population groups 
(North Europeans, Americans, Indians and Asians) in the Schofield 
database(180). The Harris-Benedict equation was also developed using 
predominantly white subjects(172). On the other hand, the Owen equation was 
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developed from a group of Caucasian, African-Americans and Asian male 
subjects, and hence, may be more accurate in predicting energy needs in 
Singaporean Chinese men(2). In addition, the subjects used in the Schofield 
study were primarily young people with relatively high activity levels. 
Labourers and miners, Italian military, Neapolitan police, Italian navy and 
Burmese hill dwellers made up the largest groups of men in the Schofield 
database(18) . In contrast, the subjects used in our study were sedentary. 
Poehlman et al. reported a higher REE in physically active individuals 
compared to those with sedentary lifestyles, even after adjustment for body 
composition(181). At the individual level, Bland Altman plots of all equations 
showed lack of agreement with measured REE with wide limits of agreement. 
Errors of REE measurement may be introduced by air leaks, incorrect 
calibration of the calorimeter, involuntary alternating periods of hyper and 
hypoventilation, fluctuating levels of fractional inspired O2 concentration, or 
acid-base disturbances(182). Although REE measurements were performed 
under strictly standardized conditions, biological intra-individual variation in 
REE might also be due to variations in eating and activity pattern in the days 
before the REE measurements. Limits of agreement within ±10% of measured 
REE are considered clinically acceptable as intra-individual variation in REE 
was reported to be 2-10% explained by methodological and biological 
variability in REE(183). However, in our study, only 70% of subjects had 
limits of agreement < 10%. Furthermore, for all equations, Bland Altman plot 
showed that bias was not consistent across the range of REE values because 
bias correlated significantly with the mean of measured and predicted REE 
(data not shown). Predicted REE typically deviated more profoundly in the 
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lower and upper REE ranges, with the equations systematically over-
estimating at lower REE and underestimating at high REE. This was also 
observed in other studies(184, 185). Considering that the average REE was 
about1600 kcal/day, an error of 10% would translate into a 160 kcal/day 
deviation from true REE. However, the Owen equation demonstrated 
individual differences between measured and predicted energy values that 
ranged from −295 to 281 kcal/day, which is about −19 to 18% of REE. If 
these equations were closely followed to establish energy intake in a 
controlled setting over the long term, energy needs could be over-predicted or 
under-predicted by the physiologic weight change equivalent of 0.3 kg/week 
or 14.4 kg/year. This is especially detrimental in the clinical setting where 
over-feeding or underfeeding may have adverse effects such as electrolyte 
imbalance and gastrointestinal problems (186). And in weight management for 
overweight and obese people, prescribed dietary plans might be ineffective in 
producing weight loss. A limitation of our study is that the REE measurements 
were made on an outpatient basis and could not be performed earlier in the 
morning. However, subjects were allowed to rest comfortably for at least 15 
min before measurement, during which they became acclimated to the 
environment, therefore ensuring resting conditions. Also, the standard 
deviation found in our study is comparable to other studies that had REE 
measurements conducted at 0700 h with the subjects staying overnight in the 
facility(36). Therefore this limitation did not add to the variability of the REE 
measured and is unlikely to affect the results reported in this paper 
These findings show that the FAO/WHO/UNU, Harris-Benedict and Mifflin 
predictive equations significantly overestimated energy needs for Singaporean 
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Chinese men, therefore usage of these equations may put them at a greater risk 
for developing obesity, especially in overweight people. We recommend the 
Owen equation for estimation of energy needs in Singaporean Chinese adult 
males at a group level due to small mean prediction error. However, the 
individual errors of the equation are too high to be of practical use in 
individuals, in situations where accurate estimation of REE is clinically 
relevant (such as when prescribing nutrition in the setting of treatment for the 
critically ill or during the treatment of obesity). Although the Owen equation 
predicted REE accurately in 73% of the subjects, it displayed wide limits of 
agreement and directional bias was observed across the range of REE. These 
wide limits of agreement were especially prominent in those with more 
extreme levels of REE. Therefore, in individuals where a precise 
determination of REE is indicated, measurement by indirect calorimetry 





Chapter 4 . Smaller size of high metabolic rate organs explains lower 
resting energy expenditure in Asian-Indian than Chinese men. 
4.1 Introduction 
Obesity is a global epidemic, as the prevalence of overweight and obesity is 
increasing not only in developed but also in developing countries (3). It is 
estimated that, by 2030, about 58% of the world population will be obese 
(Body mass index, BMI ≥ 30 kg/m2)(187). The population in Singapore 
comprises three major ethnic groups:  Chinese, Asian Indians and Malays. 
They live in a small geographic area that is highly urbanized.  The prevalence 
of obesity (defined as a BMI>=30 kg/m2) has doubled in the last decade from 
6.9% in 2004 to 10.8% in 2010.  This increase has occurred primarily 30-39 
years age group(188).  Among the ethnic groups, obesity prevalence is 
disproportionately higher in Malays (24.0%) and Asian-Indians (16.9%) than 
Chinese (7.9%). We have previously shown that over an 8-year period, Asian 
Indians and Malays gained the most weight compared to Chinese(189) 
 
Obesity is the result of an energy imbalance where chronic energy intake 
exceeds energy expenditure, resulting in adipose tissue accumulation(190).  In 
Singapore, caloric intake has been estimated to be lower in the Chinese (2367 
kcal) compared to Asian-Indians (2499 kcal) and Malays (2522 kcal) and. 
However, ethnic differences in resting energy expenditure (REE) may also be 
a contributory factor.  REE is a major component of total energy expenditure 
(TEE) and accounts for 60-70% of TEE for people leading a sedentary 
lifestyle(191). In several adult populations, reduced REE was reported to be a 
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predisposing risk factor for long-term weight gain & obesity(14, 15).  REE has 
been shown to differ between ethnic groups in studies performed in other 
populations. Many studies showed lower REE in African-American 
women(23, 192), men(21) and children(193, 194) than their White 
counterparts, independent of body weight or body composition. Soares and 
colleagues reported lower REE in Indians when compared with Westerners 
matched for body weight, but difference was no longer significant after 
adjusting for body composition(195).  
 
The primary aim of this study was to explore the association between ethnicity 
and REE in Chinese, Asian Indian and Malay men living in Singapore and to 
determine the role of potential contributors to these ethnic differences 
including fat free mass (FFM), fat mass, mass/volume of high metabolic rate 
organs (HMRO) (represented by brain volume and trunk FFM). The secondary 
aim is to examine whether inter-individual variation in circulating 
concentrations of adipokines such as leptin, adiponectin, fibroblast growth 
factor 21 (FGF21), apelin, resistin and monocyte chemoattractant protein 1 
(MCP1), help to account for inter-individual variation in REE once the effects 




4.2 Materials and methods 
4.2.1 Subjects 
244 healthy men of different ethnicities (100 Chinese, 70 Indian and 74 
Malay) were involved in this cross-sectional study. Details are described in 
Section 2.2 
4.2.2 Anthropometry & body composition  
Body weight and height were measured as previously described in Section 2.3 
Whole body and regional (trunk, arms and legs) lean body mass (LBM), fat 
mass and bone mineral content (BMC) were measured by dual-energy x-ray 
absorptiometry (DEXA; Hologic Discovery Wi) as previously described in 
Section 2.3. 
4.2.3 Measurements of resting energy expenditure 
REE was measured in the early morning after the subjects had fasted for at 
least 10 hours, by open-circuit indirect calorimetry using a ventilated hood 
system (Quark CPET, COSMED, Italy) for 60 minutes as previously 
described in Section 2.4. They were instructed to transport themselves to the 
hospital in a vehicle to avoid undue exertion. They were required to undergo a 
12 h overnight fast and refrain from intensive physical activity for 24 h prior 
to measurement. REE was calculated from VO2 and VCO2 by the Weir 
formula(163) 
4.2.4 Brain volume 
High-resolution images of the brain were acquired by magnetic resonance 
imaging using a T1- weighted MP–RAGE sequence as described in Section 
2.7.  
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4.2.5 Enzyme-linked immunosorbent assay (ELISA)  
Venous blood samples were drawn from all subjects in the morning after a 10-
hour overnight fast. Blood samples were collected according to 
recommendations of the individual assay kits’ manufacturers. Adipokines 
were measured by enzyme-linked immunosorbent assay (ELISA) as 
previously described in Section 2.10. Serum leptin was measured by ELISA 
kit (Millipore, Billerica, MA) with intra-and inter-assay coefficients of 
variation (CVs) of 3.3% and 9.4% respectively. Serum total adiponectin was 
measured by ELISA kit (Alpco Diagnostics, Salem). Intra-and inter-assay CVs 
for total adiponectin were 3.3% and 6.5% respectively. Serum apelin levels 
were determined by ELISA kit (Human Apelin ELISA kit Phoenix 
Pharmaceuticals, Belmont, CA). Intra-and inter-assay CVs were 14.2% and 
56.5% respectively. Serum FGF21, resistin and MCP1 levels were measured 
by ELISA kit (Millipore. Billerica, MA). Intra-and inter-assay CVs for FGF21 
were 3.8% and 7.4% respectively. Intra-and inter-assay CVs for resistin were 
4.5% and 14.1% respectively. Intra-and inter-assay CVs for MCP1 were 4.5% 
and 11.7% respectively.  
4.2.6 Statistical analyses 
Statistical analyses were performed using IBM SPSS Statistics for Mac 
Version 20.0; Armonk, NY: IBM Corp(196). All variables were checked for 
normal distribution, and variables with skewed distributions were log 
transformed to satisfy conditions of normality All statistical tests were two-
sided, and a P value<0.05 was considered statistically significant. All values 
were given as mean± standard error. A single regression model in which REE 
was regressed on total LBM was used to identify outliers within each ethnic 
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group. There were 9 participants with standardized residual values above 2.0 
or less than - 2.0 and these were excluded from subsequent analyses. Analysis 
of variance (ANOVA) and analysis of covariance (ANCOVA) were used for 
comparisons of continuous variables between ethnic groups with Tukey 
corrections applied for group comparisons. Multiple regression analyses were 
used to assess the contribution of independent variables (total FFM, fat mass, 
brain volume, trunk FFM and limb FFM) to the association between REE and 
ethnicity. We removed the effects of FFM and fat mass on REE to derive a 
residual variance using ANCOVA. We sought to explore how much of this 
residual variation could be explained by individual differences in circulating 
adipokines by using Pearson correlation analysis. ANCOVA models were 
constructed to test for ethnic differences in the relationship between residual 
REE and each adipokine with residual REE as the dependent variable, 
ethnicity as a factor and adipokine as a covariate. The cross-product 





4.3.1 Subject characteristics 
Ethnic differences were observed in relation to anthropometry, body 
composition and brain volume (Table 4.1). Chinese were older than Asian-
Indians. Body weight and BMI were significantly higher in Asian-Indians and 
Malays and than Chinese. After adjustment for age and body weight, trunk 
FFM was significantly lower and limb FFM was significantly higher in Asian-
Indians than Chinese even though total FFM was similar. Asian Indians had 
greater fat mass and lower brain volume than Chinese before and after 
adjustment for age and body weight. Ethnic difference in brain volume 
persists even after adjustment for differences in eTIV between Chinese and 
Asian-Indians. Unadjusted REE was not significantly associated with 
ethnicity. After adjusting for age and body weight, REE was significantly 
lower in Asian-Indians (1551± 16 kcal/day) than in Chinese (1624± 14 
kcal/day) but the difference in REE between Malays (1589± 16 kcal/day) and 





Table 4.1  Anthropometric characteristics, body composition and resting energy expenditure of study participants by ethnicity 
Mean SD Mean SD Mean SD
Age (y) 28.39 5.99 25.96 4.90 27.38 4.88 0.018
Weight (kg) 69.37 10.26 74.60 10.90 73.41 11.77 0.006 <0.001*
Height (cm) 172.03 5.83 173.44 5.77 171.35 6.70 0.120 0.138*
BMI (kg/m2) 23.39 2.88 24.78 3.20 24.98 3.56 0.002 <0.001*
Fat Mass (kg) 14.63 5.27 17.93 6.52 17.34 7.41 0.002 0.081
Total FFM (kg) 52.94 6.52 55.02 5.93 54.15 5.92 0.10 0.145
Trunk FFM (kg) 24.80 3.09 25.08 2.96 24.86 2.78 0.83 <0.001
Limb FFM (kg) 24.10 3.44 26.21 3.01 25.31 3.06 <0.001 0.117
Brain volume (cm3) 1.20 0.08 1.14 0.10 1.18 0.10 0.001 <0.001
eTIV 1.42 0.16 1.36 0.13 1.40 0.16 0.051 0.134
REE (kcal/day) 1594 191 1579 164 1604 181 0.71 0.004
a
 P ANOVA value for  comparison between ethnic groups 
b
 P ANOVA value for comparison between the ethnic groups adjusted for age and body weight
* adjusted for age only and not body weight
P value b
Chinese (N=96) Asian-Indian (N=68) Malay (N=71)
P value  a
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4.3.2 Correlations between resting energy expenditure with anthropometry, body 
composition and brain volume 
 
Univariate correlation analyses showed that REE was positively associated with 
weight, BMI, fat mass, total and regional FFM across all ethnic groups (Table 4. 2). 
Compared with fat mass, REE correlated more strongly with total FFM and regional 
FFM distribution. The positive association between REE and brain volume was 








Table 4.2 Pearson correlation coefficients between resting energy expenditure with age, anthropometry and body  
composition by ethnic group.   
 
R P Value R P Value R P Value
Age (y) -0.105 0.31 0.202 0.099 0.14 0.244
Weight (kg) 0.666 <0.001 0.688 <0.001 0.666 <0.001
Height (cm) 0.463 <0.001 0.325 0.007 0.412 <0.001
BMI (kg/m2) 0.536 <0.001 0.592 <0.001 0.523 <0.001
Fat Mass 0.37 <0.001 0.446 <0.001 0.478 <0.001
Total FFM 0.731 <0.001 0.76 <0.001 0.677 <0.001
Trunk FFM 0.695 <0.001 0.78 <0.001 0.684 <0.001
Limb FFM 0.719 <0.001 0.687 <0.001 0.633 <0.001
Brain volume (cm3) 0.137 0.211 0.077 0.547 0.36 0.003
 Significant correlation is indicated as bold.
Chinese (N=96) Asian-Indian (N=68) Malay (N=71)
 73
4.3.3 Contribution of body composition and high metabolic rate organs to ethnic 
differences in resting energy expenditure 
Given that REE differed significantly between Asian-Indians and Chinese, we used 
linear regression models to investigate whether differences in body composition and 
HMRO could account for ethnic difference in REE (Table 4.3). In Models 1 to 3, total 
FFM (P<0.001), fat mass (P=0.008) and brain volume (P=0.016) were significant 
determinants of REE, independent of ethnicity and explained 54.7% of the variance in 
REE. Total FFM was the strongest single determinant of REE, which alone accounted 
for 50.5% of the between-subject variation in REE (data not shown), with relatively 
minor contributions of ethnicity (1.8%), fat mass (1.1%) and brain volume (1.3%). 
REE remained significantly lower in Asian-Indians than Chinese (54±22 kcal/day) 
after adjustment for FFM, fat mass and brain volume. When trunk FFM was added in 
place of total FFM in Model 4, the difference in REE between Asian-Indians and 
Chinese was no longer statistically significant (25±22 kcal/day) while using limb 
FFM ratio in place of total FFM in Model 4 increased the magnitude of difference 
(85±23 kcal/day) in REE. 
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Table 4.3 Resting energy expenditure linear regression models 
Model and variable B SE Beta P value R2 
Model 1: REE = ethnicity + total FFM 0.523
Constant 476.943 71.514 <0.001
Asian-Indian -59.065 20.002 -0.149 0.003
Malay -15.619 19.629 -0.04 0.427
Total FFM 21.097 1.329 0.728 <0.001
Model 2: REE = ethnicity + Total FFM + Fat Mass 0.534
Constant 511.086 72.285 <0.001
Asian-Indian -66.96 20.089 -0.169 0.001
Malay -22.904 19.683 -0.059 0.246
Total FFM 19.515 1.477 0.674 <0.001
Fat mass 3.389 1.438 0.122 0.019
Model 3: REE = ethnicity + Total FFM + Fat Mass + Brain 0.547
Constant 276.377 122.155 0.025
Asian-Indian -53.952 21.505 -0.136 0.013
Malay -19.615 20.454 -0.05 0.339
Total FFM 18.681 1.57 0.645 <0.001
Fat Mass 4.057 1.516 0.146 0.008





Model and variable B SE Beta P value R2 
Model 4: REE = ethnicity + Trunk FFM  + Fat Mass + Brain
Constant 312.103 123.341 0.012 0.533
Asian-Indian -25.131 21.744 -0.064 0.249
Malay 1.141 20.829 0.003 0.956
Trunk FFM 38.445 3.362 0.631 <0.001
Fat Mass 3.87 1.56 0.14 0.01
Brain 227.05 93.955 0.122 0.017
Model 5: REE = ethnicity + Limb FFM + Fat Mass + Brain 0.52
Constant 346.73 124.185 0.006
Asian-Indian -84.8 22.601 -0.214 <0.001
Malay -39.507 21.158 -0.101 0.063
Limb FFM 33.162 3.002 0.611 <0.001
Fat Mass 5.491 1.517 0.198 <0.001






4.3.4 Relations between residual resting energy expenditure and adipokine 
concentrations 
Figure 4.1 shows the relationships between residual REE (difference between 
measured REE and REE predicted on the basis of FFM and fat mass) and adipokines. 
Adiponectin trended to correlate positively with residual REE in Chinese (r=0.181, 
P=0.081) but not Asian-Indians (r=-0.077, P=0543) and Malays (r=0.028, P=0.815). 
Apelin trended to correlate positively with residual REE in Malays (r=0.219, 
P=0.066) but not Chinese (r=0.097, P=0.351) and Asian-Indians (r=0.07, P=0.572). 
MCP1 was positively with residual REE only in Malays (R= 0.303, P=0.021) but not 
Chinese (R =-0.142, P=0.235) and Asian-Indians (R= 0.157, P=0.28). Higher 
circulating levels of resistin were associated with greater residual REE only in Asian-
Indians (R= 0.275, P= 0.028) but not Chinese (R=-0.04, P=0.714) and Malays(R=-
0.189, P=0.114). No significant associations between residual REE with leptin and 
FGF21 were observed. A significant effect modification by ethnicity was noted for 








Figure 4.1 Plots of residual resting energy expenditure (difference between 
resting energy expenditure measured and resting energy expenditure predicted 





In this study, we have shown that, after controlling for body weight, Asian Indians 
exhibit lower REE than Chinese.  This confirms earlier findings in a study of Henry 
and Rees, showing that the Schofield equation overestimated REE in Chinese, Malay 
and Indian men by 7.6%, 9.3% 12.8% respectively, suggesting that REE of Chinese is 
higher compared with their Asian Indian counterparts(131). This ethnic difference 
could contribute to the excess levels of obesity seen in Asian Indians in Singapore.  
Even though the difference in REE was relatively small (≈70 kcal/day), over a 
prolonged period, this degree of caloric excess could give rise to excess body weight 
of ≈ 2.3 kg per decade in Asian-Indians compared to Chinese, assuming that the 
energy intake is held constant(197).  In contrast, after controlling for body weight, 
Malays had similar REE to Chinese suggesting that in this ethnic group, the high 
prevalence of obesity is likely to result largely from excessive energy intake, and not 
to differences in energy expenditure.  
 
Previous studies that have examine ethnic differences in REE between Chinese, 
Malays and Asians Indians (131) have relied primarily on body weight, and not body 
composition, to estimate REE.  By studying differences in body composition between 
ethnic groups, we believe that we may be able to explain these ethnic differences in 
REE. In all three ethnic groups, we found that FFM, brain volume and fat mass were 
independent determinants of REE in Chinese, Asian Indian and Malay men. Total 
FFM was the strongest determinant of REE accounting for half of the variance in 
REE.  It is noteworthy that the contribution of FFM to REE in our study was lower 
than that reported by Gallagher et al and many authors (2, 24, 198-200) where FFM 
explained 60-85 % of the variance of REE.  It has been argued that the close 
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relationship between FFM and REE reported by many studies is artificial and 
attributable to the large heterogeneity of the subject population. If there is a wide 
range in body weight or FFM in a given population, the contribution of FFM to REE 
is strong(28). The variation (SD) in FFM in our study (5.9-6.5 kg) was smaller 
compared to that reported by Gallagher et al (7.1-8.5 kg). Our findings is consistent 
with the study of Karhunen et al who reported that FFM accounted only 43% of the 
variation in REE due to the homogenous study group(29). We also found that brain 
volume was independently associated with REE and explained an additional 1% of 
the variance in REE over and above that explained by FFM(33). Among the HMRO, 
brain has one of the highest specific metabolic rates (240 kcal/kg/day) and contributes 
23% of total REE even though its weight is only 2% of total FFM(1). Gallagher et al 
(1)estimated the variation (SD) in brain size of adults to be 0.15 kg in men, which is 
similar to what we observed in our study population. Therefore, due to the small 
variation in the brain size, it is not surprising that it does not make a significant 
contribution to the variation in REE. Another probable reason could be due to the 
weak association observed between variation in body size and brain mass(1). Despite 
the low metabolic activity of adipose tissue (4.5 kcal/kg), fat mass was a significant 
predictor of REE, independent of the effects of FFM, probably due to the wide range 
in BMI of our study population (18.5 -30.0 kg/m2). Thus, FFM, FM and brain volume 
contribute independently, and to a different extent, to REE.   
 
Our data shows that these parameters differ between ethnic groups and may 
contribute to the ethnic differences in REE.  Specifically, although Asian-Indians 
have greater total FFM compared to Chinese, the trunk FFM and brain volume are 
lower and limb FFM are higher. This is important because the trunk FFM includes the 
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high metabolic rate organs (HMRO) including liver, heart, spleen and kidneys.  The 
HMRO (brain, liver, heart, spleen and kidneys) represent only less than 6% of total 
body weight, but consume approximately 60-70% of the energy expended by fat-free 
tissue. In contrast, the less metabolically active skeletal muscle, found in the limbs, 
comprises 40-50% of total body weight while accounting for only 20-30% of REE(1, 
27). When we adjusted for trunk FFM, rather than total FFM, the difference in REE 
between Asian Indians and Chinese is attenuated and is no longer statistically 
significant.   These findings are thus consistent with the hypothesis that Asian Indians 
have a smaller proportion of their lean tissue as HMROs and a larger proportion as 
skeletal muscle resulting in a lower REE for any given level of total FFM(22). 
Previous studies have shown that variation in the organ-tissue proportion of FFM 
affects ethnic variability in REE independent of the differences in FFM. Hunter et al 
found that after differences in trunk LBM measured by DEXA were taken into 
account, the REE difference between premenopausal, nonobese African American 
and Caucasian women disappeared suggesting that the lower REE in African 
Americans may be mediated by a lower volume fraction of metabolically active organ 
mass(22). Gallagher et al confirmed the results of Hunter et al by showing that racial 
differences in REE were no longer significant after accounting for masses of high 
metabolic rate organs (liver, kidney, spleen, heart) which were measured by MRI(33).  
 
Next, we examined the roles of adipokines on REE, independent of the effects of 
FFM and fat mass. We observed significant links between residual REE with MCP1 
in Malays and resistin in Asian-Indians. The present study shows high MCP1 and 
resistin in subjects with high REE. To our knowledge, the physiologic roles of MCP1 
and resistin in energy expenditure in humans remain largely undetermined. However, 
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we postulate that MCP1 and resistin may promote chronic low-grade inflammation 
through pro-inflammatory cytokines, increasing energy expenditure in a regulatory-
feedback manner to prevent fat accumulation in obesity(63-67). MCP1 is a key 
molecule that mediates infiltration of adipose tissue macrophages (ATM), the 
dominant source of production of pro-inflammatory cytokines such as tumor necrosis 
factor- α (TNF-α), interleukin-6 (IL-6) and plasminogen activator inhibitor-1 (PAI-1) 
during adipose tissue expansion(68). Resistin has been linked to chronic low-grade 
inflammation as it is homologous to FIZZ1 (found in inflammatory zone 1) and 
primarily expressed and secreted from monocytes in humans(201, 202). In obese 
adolescents (203) and adults with obesity and T2DM(204, 205), plasma resistin 
correlated positively with pro-inflammatory factors. Recently, Lee et al demonstrated 
that human resistin directly binds to adenylyl cyclase associated protein 1 (CAP1) in 
monocytes and upregulates cyclic AMP (cAMP) concentration, protein kinase A 
(PKA) activity, and NF-k B-related transcription of inflammatory cytokines(206). 
These pro-inflammatory cytokines may regulate energy balance by acting in the 
hypothalamus of central nervous system(207, 208) and activating thermogenic 
transcriptional co-activator PGC1-α through phosphorylation by p38 MAP kinase in 
peripheral tissues(209). Tang et al demonstrated that aP2-p65 transgenic mice with 
adipose tissue-specific overexpression of the NF-kB p65 subunit exhibited elevated 
expression of pro-inflammatory genes (MCP-1, TNF-α, IL-6) and were protected 
from HFD induced obesity and insulin resistance by increased energy 
expenditure(64). Jiao et al reported that adipose tissue specific IKKβ-overexpressing 




We also observed a trend of higher residual REE with higher apelin levels in Malays. 
To our knowledge, this is the first study to explore the relationship between apelin 
and REE in humans.  The mechanisms underlying this observation could be mediated 
by upregulation of brown adipose tissue uncoupling protein 1 (UCP1) activity(60), 
stimulation of AMP-activated protein kinase (AMPK)-dependent pathway(61) or 
increased mitochondrial biogenesis in skeletal muscle(62). A trend of positive 
association between residual REE with adiponectin was also seen in Chinese. Our 
results support the study of Kim et al who reported positive association between 
serum adiponectin and REE adjusted for body weight in overweight and obese 
adolescents(6). Other studies(49, 50) have shown negative associations between total 
adiponectin and REE even after adjustment for body composition while others have 
failed to replicate this result(51, 52).(210)  
 
In our study, leptin was not associated with residual REE once the effects of FFM and 
fat mass had been removed. This means that if an individual had a high concentration 
of circulating leptin, this had no effect on whether they have high or low REE for 
their FFM and fat mass. This is consistent with other studies that reported no 
associations between leptin levels and REE(47, 48). Reports have shown that humans 
lacking functional leptin production do not have a significantly altered REE(211). 
Treatment of long-acting pegylated human recombinant leptin in obese men for 12 
weeks also produced no effect on weight loss or energy expenditure(211). In contrast, 
studies in rodents have shown the potential role of leptin in energy metabolism. 
Administration of recombinant leptin in genetically obese and diet-induced obese 
mice induces weight loss, by decreasing food intake and increasing resting and 
physical energy expenditures(8). The discrepancies in the effects of leptin between 
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human and rodents could be because laboratory rodents are routinely kept in 
temperatures below the thermoneutral zone. The effects of leptin on REE of mice may 
reflect the influence of brown adipose tissue thermogenesis. In adults, REE is 
measured at thermoneutral temperatures and brown adipose tissue levels are too low 
to be of functional significance for thermoregulation. We also did not find any 
significant association between FGF21 and the residual variation in REE. Lee et al 
recently reported that in humans, mild cold-induced increase in FGF21 was associated 
with cold induced thermogenesis independent of age, gender, fat mass, and lean 
mass(55). They went on further to show that FGF21 treatment enhanced brown fat 
thermogenesis in human adipocytes in a depot-specific manner(56). These suggest 
that FGF21 may be involved only in adaptive thermogenesis but not REE. Overall, 
ethnicity seem to modulate the relationships between residual REE and adipokines. 
Reasons for ethnic differences in adipokine regulation of REE are unclear at the 
moment.  
 
There are limitations in our study. Subjects were not selected from a larger 
representative population sample and included only young healthy men who have low 
risk of diabetes or cardio-metabolic diseases. However, this is the age range where the 
greatest weight gain occurs in our population (189)and thus represents a highly 
relevant population for the prevention of obesity.  Furthermore, excluding those with 
established diabetes or other diseases avoids the potential confounding or bias that 
could result from the treatment of these conditions.  Nonetheless, we recognize that 
our study did not include women, and if anything, Malay and Asian Indian women in 
Singapore are more affected by obesity than men(189). It will be important to extend 
the findings in this study to women taking into account variation in REE that occurs 
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in different phases of the menstrual cycle. Despite the advantage of using DEXA to 
study body composition, this methodology is not without limitations. Trunk FFM and 
limb FFM are only crude surrogates of HMRO and muscle mass respectively. DEXA 
is incapable of distinguishing among the various organs and tissues that make up 
trunk FFM. Studies that have used trunk FFM measured by DEXA were subsequently 
validated using more sophisticated techniques such as MRI and this gives us 
confidence that trunk FFM really does reflect the mass of HMRO. However, we 
recognize that a more precise quantification of these organs man explain a greater 
proportion of REE. Furthermore, we only assessed the mass/volume of HMRO.  
Ethnic differences may exist in the specific metabolic rates of organs and tissues that 
could explain the differences in REE better than mass/volume. However, this has yet 
to be investigated. A disadvantage of cross-sectional nature of this study is that it does 
not definitively establish causal or temporal relationships, and should be considered 
hypothesis generating only. 
 
In conclusion, we have found that Asian Indian men exhibit lower REE than Chinese 
men for the same body weight.  These differences may contribute to the higher 
prevalence of obesity in this ethnic group.  Lower REE in Asian-Indian men may be 
mediated by smaller size of high metabolic rate organs in the trunk and the brain. To 
prevent obesity in Asian-Indians, the recommended dietary allowance for energy 
intake should take into account the lower REE in this ethnic group, and not only on 
age and body weight as currently recommended by the WHO. In addition, 
adiponectin, apelin, MCP1 and resistin may be important physiologic candidates that 
may explain inter-individual variability in REE in different ethnic groups. 
Consequently, future investigations examining the role of adipokines in the regulation 
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Chapter 5 : Metabolic Flexibility Differs among Asian Ethnic Groups in Healthy 
Lean but not in Overweight or Obese Individuals 
5.1 Introduction 
Metabolic flexibility (MF) is defined as the capacity of the organism to match fuel 
oxidation to fuel availability(130). In lean insulin-sensitive individuals, skeletal 
muscle displays MF with the capacity to increase fat oxidation during fasting and to 
readily switch from fat oxidation to carbohydrate (CHO) oxidation under insulin 
stimulation (e.g. during postabsorptive conditions) (212, 213). Conversely, the 
inflexible skeletal muscle of obese insulin-resistant or type 2 diabetic (T2D) 
individuals has impaired ability to readily switch from fat oxidation to CHO oxidation 
in response to insulin(132, 214). Compared with insulin-sensitive individuals, obese 
insulin-resistant and T2D individuals show higher fasting RQ (132, 214) and blunted 
increase in RQ during a hyperinsulinemic euglycemic clamp (HEC) (134, 212).  
 
Obesity and insulin resistance are highly correlated.  It remains unclear whether the 
associations between obesity and insulin resistance are independently correlated with 
MF. Furthermore, MF may differ between ethnic groups. African American men have 
higher fasting and 24-h RQ than Caucasian men(21). Impaired substrate switching in 
African American compared to Caucasian women during a high fat diet challenge, 
two-step pancreatic euglycemic clamp and epinephrine infusion is also observed, 
which could partly explain the greater prevalence of obesity and insulin resistance in 
African Americans(140). Among Asian ethnicities, Chinese, Malays and Asian-
Indians have different propensity to develop insulin resistance, obesity and T2D. 
However, MF has not been examined in these ethnic groups.  This may be particularly 
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important given that these, and related, populations, represent up to 2/3 of the world’s 
population.  
 
In this study, we examined the relationship of MF with ethnicity, obesity and insulin 
resistance.  We further sought to understand any associations observed could be 
explained by a) plasma metabolic intermediates (acylcarnitines, organic acids and 
amino acids) using metabolic profiling, and b) plasma levels of adipokines  such as 
leptin and adiponectin which have been shown to modulate skeletal muscle substrate 
utilizations (46, 215, 216).  
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5.2 Materials and Methods 
5.2.1 Subjects 
We studied 219 healthy adult males of three of the major ethnic groups (90 Chinese, 
65 South Asians and 64 Malays) living in Singapore. Details of the subject’s selected 
were previously described in section 2.2.  
5.2.2 Anthropometry and body composition measurement  
Body weight and height were measured as previously described in Section 2.3. Body 
composition was measured by dual-energy x-ray absorptiometry (DEXA; Hologic 
Discovery Wi) as previously described in Section 2.3.  
5.2.3 Measurement of respiratory quotient 
Indirect calorimetry was performed in the early morning after a 10-hour overnight 
fast.  Subjects were also asked to refrain from intensive physical activity 24 h prior to 
measurement. Measurements of oxygen consumption (VO2) and carbon dioxide 
production (VCO2) were performed by open-circuit indirect calorimetry using a 
ventilated hood system (Quark CPET, COSMED, Italy) for 1-hour in the fasting 
condition as previously described. Measurements of VO2 and VCO2 were 
continuously measured for a further 3 hours following a mixed-meal tolerance test 
(MMTT). The MMTT was a standardized liquid meal (Ensure Plus®, Abbott 
Nutrition, Abbott Laboratories, Columbus, OH) with a total calorie content of 600kcal 
which comprised 55% from carbohydrates, 30% from fat (10% saturated fats, 10% 
polyunsaturated fats, 10% mono-unsaturated fat), and 15% from protein. RQ was 
calculated from VO2 and VCO2 as follows: RQ=VCO2/VO2. RQ incremental area 
under the curve [RQ (iAUC)] = total AUC/min – fasting value) was utilized as a 
measure of MF(136). 
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5.2.4 Measurement of adipose depots 
Liver fat content and intramyocellular lipids (IMCL) were determined using 1H MRS 
using a tesla MR scanner (Tim Trio, Siemens) as previously described in Section 2.5. 
Total visceral (VAT) and subcutaneous (SAT) abdominal adipose tissue volumes 
were measured by magnetic resonance imaging (MRI) as previously described in 
Section 2.6.  
5.2.5 Hyperinsulinemic-euglycemic clamp 
Insulin sensitivity was assessed after a 10-hour overnight fast using the 
hyperinsulinemic euglycemic clamp technique as previously described in Section 2.8. 
Insulin was infused at a fixed rate of 40 mU/m2 body surface area/minute for 120 min 
during the clamp, and an infusion of 20% glucose was adjusted to maintain a constant 
blood glucose of 90 mg/dL. Insulin sensitivity index (ISI) was calculated using the 
mean glucose infusion rate and steady state insulin concentrations during the final 
30min of the clamp. 
5.2.6 Enzyme-linked immunosorbent assay  
 
Venous blood samples were drawn from all subjects in the morning after a 10-hour 
overnight fast. Serum and plasma samples were frozen and stored at -80 °C until tests 
were performed. Serum leptin and adiponectin were measured by enzyme-linked 
immunosorbent assay (ELISA) (Millipore, Billerica, MA) as previously described in 
Section 2.10. Serum leptin was measured by ELISA kit (Millipore, Billerica, MA) 
with intra-and inter-assay coefficients of variation (CV) of 3.3% and 9.4% 
respectively. Plasma adiponectin was measured by ELISA kit (Alpco Diagnostics, 
Salem). The intra-and inter-assay CVs for adiponectin were 3.3% and 6.5% 
respectively.  
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5.2.7 Metabolomic Profiling of Organic Acids, Acylcarnitines and Amino acids 
 
Plasma and urine samples were obtained after an overnight fast and 4 h after MMTT. 
Samples were prepared and stored at -80 °C for later analysis. Acylcarnitines and 
amino acids were analysed in plasma by tandem MS (MS/MS), and urine organic 
acids by GC/ MS(170). All MS analyses employed stable-isotope dilution with 
internal standards from Isotec (St Louis, MO, USA), Cambridge Isotope Laboratories 
(Andover, MA, USA) and CDN Isotopes (Pointe-Claire, QC, Canada Samples) 
5.2.8 Statistical Analysis  
 
Statistical analyses were performed using IBM SPSS Statistics for Mac Version 20.0; 
Armonk, NY: IBM Corp(196). All statistical tests were two-sided, and a P value<0.05 
was considered statistically significant. All values were given as means ± SD. All 
variables were checked for normal distribution, and variables with skewed 
distributions were log transformed to improve normality. Pearson’s correlation 
analysis was used to assess the relationships between RQ (iAUC) and continuous 
variables with adjustment for age. The independent t-test was used for two-group 
comparisons of continuous variables, and ANOVA was used for comparisons in more 
than two groups, with post hoc Tukey test for pairwise comparisons. ANCOVA was 
performed to adjust for covariates. To examine whether ethnicity influence the 
relationship between RQ (iAUC) and measures of adiposity and RQ (iAUC) and 
insulin sensitivity, we used ANCOVA models with an interaction term “ethnicity X 
adiposity” included as an independent variable. Repeated-measures ANOVA were 
used to assess the changes in RQ during MMTT by ethnicity, obesity status and time. 
The Greenhouse-Geisser adjustment was used when the sphericity assumptions were 
not fulfilled. Principal components analysis (PCA) was used to reduce a large number 
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of correlated variables into uncorrelated factors that account for the variance in the 
dependent variable. The fasting-to-postprandial difference (FPPD) (postprandial – 
fasting concentration) was calculated for each metabolite.  PCA was performed using 
varimax rotation on the change scores of all measured metabolites and hormones 
without prior knowledge of ethnicity. Factors with an eigen value ≥2.0 were identified 
and metabolites with a factor load ≥0.4 were reported as composing a factor. The 
level of each factor was compared among ethnic groups and between lean and 




5.3.1 Subject characteristics 
 
Table 5.1 shows the demographic and clinical characteristics of study participants. 
Asian-Indians were younger, had greater BMI, %body fat and SAT, but lower VAT 
and VSR compared with Chinese. IMCL was higher among Asian-Indians than 
Chinese, but hepatic fat was not significantly associated with ethnicity. There were no 
significant differences between ethnic groups for fasting NEFA and glucose but 
fasting insulin level was higher in Asian-Indians than Chinese. Fasting leptin 
concentrations were higher in Chinese than Malays and Asian-Indians. However, no 
significant differences between ethnicities were observed for fasting adiponectin 














Table 5.1 Demographic and clinical characteristics of study participants by ethnicity 
Mean SD Mean SD Mean SD P value a P value b
Age (y) 28.14 5.82 25.74 4.67 27.13 4.96 0.02
Weight (kg) 69.58 10.23 75.00 10.84 73.20 11.49 0.01 0.00
Height (cm) 172.01 5.72 173.68 5.76 171.37 6.31 0.07 0.08
BMI (kg/m2) 23.47 2.86 24.85 3.20 24.92 3.65 0.01 <0.001
Total body fat % 21.06 5.47 24.18 5.95 23.19 6.88 0.01 <0.001
VAT (L) 964.03 599.18 1158.99 745.24 1077.64 694.81 0.49 0.02
SAT (L) 2018.27 950.68 2794.23 1394.13 2622.51 1428.77 <0.001 <0.001
VSR 0.49 0.21 0.41 0.18 0.43 0.17 0.04 0.19
IMCL 9.25 4.08 12.94 6.22 10.23 4.91 <0.001 <0.001
Hepatic fat (%) 9.07 8.17 10.33 9.86 9.60 9.45 0.89 0.40
ISI 11.12 5.21 8.34 3.77 10.46 5.78 <0.001 <0.001
NEFA 0.45 0.20 0.51 0.24 0.47 0.21 0.23 0.42
Insulin  (mU/L) 11.03 9.90 15.99 23.01 11.08 7.12 0.03 <0.001
Glucose  (mmol/L) 4.53 0.43 4.47 0.36 4.51 0.29 0.66 0.92
Leptin (ng/mL) 2.00 1.49 3.35 2.28 3.25 2.27 <0.001 <0.001
Adiponectin (ng/ml) 3658.30 1446.29 3867.33 1476.15 3421.85 1474.77 0.23 0.33
a P value for comparison between ethnic groups 
b P balue for comparison between ethnic groups adjusted for age
Chinese (N=90) Asian-Indian (N=65) Malay (N= 64)
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5.3.2 Relationships between RQ (iAUC) with age and metabolic parameters 
Table 5.2 shows the relationship between RQ (iAUC) and a number of physiologic 
variables including measures of age, adiposity, insulin sensitivity. Age was 
significantly associated with RQ (iAUC) in Asian Indians and Malays and therefore, 
other all analyses were adjusted for age where applicable. Overall, RQ (iAUC) 
negatively correlated with measures of adiposity (BMI, % body fat, SAT and VAT) 
across all ethnic groups. These relationships remained statistically significance with 
further adjustment for ISI (data not shown). Liver fat content was also negatively 
correlated with RQ (iAUC) but this reached statistical significance only in Asian-
Indians and Malays.  After adjustment for BMI, the associations between RQ (iAUC) 
with VAT, SAT and liver fat were no longer statistically significant. RQ (iAUC) was 
positively correlated with ISI among Malays only but this relationship disappeared 
when adjusted for BMI   
 
Since the correlation coefficient between RQ (iAUC) and measures of adiposity were 
generally smaller in Chinese than in Asian Indians and Malays, we next examined the 
interaction between adiposity X ethnicity in relation to RA(iAUC).  Figure 5.1 shows 
the effect of ethnicity on the relationship between RQ (iAUC), adiposity and insulin 
sensitivity. Effect modification by ethnicity was noted for the association between RQ 
(iAUC) and measures of adiposity which reached statistical significance for BMI 
(P=0.051), %body fat (P=0.046) and VAT (P=0.028) between Malays and Chinese. 
At lower BMI, %body fat, VAT, hepatic fat content and IMCL, Malays and Asian-
Indians had significantly higher RQ (iAUC) than Chinese. However at greater BMI, 
%body fat, SAT, VAT, hepatic fat content and IMCL, the RQ (iAUC) was no longer 
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different among the ethnic groups or became lower among Malays and Asian-Indians 
than Chinese.    
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Table 5.2 Pearson correlation coefficients between RQ (iAUC) with age, adiposity, insulin sensitivity and fasting concentrations of 
adipokines by ethnicity. 
 
Age Age and BMI Age Age and BMI Age Age and BMI
Age -0.031 0.772 -0.451 <0.001 -0.35 0.005
BMI -0.244 0.023 -0.392 0.001 -0.559 <0.001
Body fat % -0.244 0.023 -0.439 <0.001 -0.518 <0.001
VAT -0.252 0.027 0.387 -0.3 0.021 0.431 -0.481 <0.001 0.308
SAT -0.271 0.017 0.291 -0.388 0.002 0.967 -0.493 <0.001 0.819
IMCL 0.161 0.176 0.07 -0.205 0.125 0.962 -0.152 0.259 0.352
Liver Fat -0.157 0.194 0.908 -0.365 0.004 0.239 -0.354 0.008 0.993
ISI -0.033 0.762 0.084 0.167 0.196 0.476 0.386 0.002 0.517
Leptin -0.219 0.056 -0.352 0.007 -0.384 0.004
Adiponectin 0.049 0.657 0.003 0.981 0.122 0.344
Significant correlation is indicated as bold



















Figure 5.1 Age-adjusted fitted regression plots of RQ (iAUC) against BMI, % 
body fat, visceral adipose tissue (VAT, cm3), subcutaneous adipose tissue (SAT, 
cm3), intramyocellular lipids (IMCL) and liver fat (%) for Chinese (blue circle), 
Asian Indians (red square) and Malays (green triangle). Relationship between 
RQ (iAUC) and A: BMI (Asian-Indian P interaction= 0.149, Malay P interaction 
= 0.051). B: % body fat (Asian-Indian P interaction=0.084, Malay P 
interaction=0.046,). C: VAT (Asian-Indian P interaction =0.122, Malay P 
interaction=0.028). D: SAT (Asian-Indian P interaction=0.145, Malay P 
interaction =0.154). E: IMCL (Asian-Indian P interaction =0.012, Malay P 







5.3.3 Impact of ethnicity and obesity on RQ (iAUC) 
To better illustrate the associations between obesity, ethnicity and RQ (iAUC), we 
stratified our data into those who were lean, vs. overweight/obese.  Figure 5.2 shows 
whole body RQ at fasting and after the mixed- meal challenge with time.  In the 
fasting state, the RQ was similar between lean and overweight/obese subjects, and 
there was no statistically difference between ethnic groups (Figure 5.2 A). The change 
in RQ following MMTT was statistically significantly (P value for the effect of time 
<0.001)(Figure 5.2 B). The ability to switch from fat to CHO oxidation, expressed as 
an increase in RQ (iAUC), was significantly different between ethnic groups 
(P<0.001), and between lean and overweight/obese subjects (P<0.001)(Figure 5.2 C). 
Among lean subjects, the RQ (iAUC) was significantly lower in Chinese (0.010 ± 
0.004) compared with Asian-Indians (0.035±0.005, P<0.001) or Malays 
(0.037±0.005, P<0.001).  These ethnic differences in RQ (iAUC) between ethnic 
groups were still statistically significant (P<0.001) after correcting for age and other 
measures of adiposity (%body fat, VAT, SAT, IMCL and hepatic fat content). Among 

















Figure 5.2 (A): Fasting respiratory quotient (RQ). (B): Postprandial RQ after MMTT in Chinese, Asian Indians and Malays stratified 
into lean and overweight/obese groups. P value for the effect of time was <0.001. (C): RQ (iAUC) defined as incremental postprandial 
area under the curve. Ethnicity effect was P<0.001, obesity effect was P<0.001. Values represent means ± SD. * P<0.001 compared to 
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5.3.4 Metabolomic profiling 
To gain a more comprehensive snapshot of changes in metabolic fuel selection in 
the fasted/fed transition, we measured a broad panel of acylcarnitines, amino acids 
and organic acids that serve as substrates and products of key metabolic pathways at 
fasting and 4 hours after MMTT. PCA was used to consolidate the fasting to 
postprandial difference (FFPD) in metabolites into 6 factor components (FC) 
grouping in biologically plausible clusters (Table 5.3). Ethnic differences in the 
associations between RQ (iAUC) and FCs were observed (Table 5.4). FC1 which 
composed of C10, C12:1, C12, C10:1, C14:1, C14:2, C8, C6-DC/C8-OH, C10-
OH/C8-DC, C16:1, C16:2, C14 negatively correlated with RQ (iAUC) only in 
Chinese and Malays but not in Asian-Indians, whereas FC6 which composed of 
pyruvate and lactate positively correlated with RQ (iAUC) only in Asian-Indians and 
Malays but not in Chinese. Significant effect modification by ethnicity was noted for 
the association between RQ (iAUC) and FC6 (P=0.005) but not FC1 (P=0.189). 
When stratified by BMI, no ethnic differences in FC1 were observed in both lean and 
overweight/obese individuals (Figure 5.3). FC6 was significantly associated with 
ethnicity (P=0.015) and obesity category (P<0.001). Among the lean individuals, FC6 
was significantly higher in lean Asian-Indians (0.75 ± 0.18, P=<0.001) and Malays 
(0.34 ± 0.17, P=0.043) compared to Chinese (-0.099 ± 0.13), even after adjusting for 
age. Among overweight/obese individuals, there were no ethnic differences in FC6. 





Table 5.3 PCA-derived factor components (FCs) 
 
Factor Description Components
3 Ketone related Total ketones, β-hydroxybutyrate, C2, C4-OH, non-esterified fatty acids (NEFA), 
4 Medium-chain acylcarnitines C14:1-OH, C14-OH/C12-DC, C20, C18-OH/C16-DC, C4DC/Ci4DC, C12-OH/C10-DC
5 Long-chain acylcarnitines C18, C16, C18:2, C18:1
6 Glycolysis Lactate, pyruvate
C10, C12:1, C12, C10:1, C14:1, C14:2, C8, C6DC/C8OH, C10OH/C8DC, C16:1, C16:2, 
C14
Phenylalanine, Methionine, Leucine/Isoleucine, Valine, Proline, Tyrosine, Arginine, 







Table 5.4 Pearson correlation coefficients between RQ (iAUC) with factor components (FCs) by ethnicity, adjusted by age 
 
Correlation coefficient P value Correlation coefficient P value Correlation coefficient P value
FC1 -0.275 0.01 -0.14 0.279 -0.377 0.003
FC2 0.098 0.365 0.088 0.497 0.054 0.677
FC3 -0.025 0.819 -0.068 0.601 -0.103 0.424
FC4 -0.04 0.711 0.022 0.867 -0.157 0.223
FC5 -0.166 0.124 -0.116 0.37 -0.015 0.911
FC6 -0.006 0.953 0.385 0.002 0.269 0.034






























Figure 5.3 PCA derived factor components (FC) in Chinese, Asian Indians and 
Malays stratified into lean and overweight/obese groups. *P<0.001 compared to 
lean Chinese, # P<0.05 compared to lean individuals of each ethnic group 
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5.3.5 Adipokines 
Next we wanted to see if adipokines such as leptin and adiponectin could explain the 
ethnicity interaction with BMI for RQ (iAUC). Leptin has negative correlation with 
RQ (iAUC) across all ethnic groups, reaching statistical significant in Asian-Indians 
(r=-0.352, P=0.007) and Malays (r=-0.384, P=0.004) and borderline significance in 
Chinese (r=-0.219, P=0.056). There were no significant associations between RQ 
(iAUC) with adiponectin (data not shown). Since leptin correlated significantly with 
RQ (iAUC), we examined the associations between leptin and BMI. A positive 
association between leptin and BMI was observed across all ethnic groups and most 
pronounced in Malays (r=0.756, P<0.001) than Chinese (r=0. 651, P<0.001) and 
Asian-Indians (r= 0.605, P<0.001). Upon adjustment for leptin, the significant 
association between RQ (iAUC) and BMI disappeared in Chinese (r= -0.137, 




In Asian men, fasting RQ was not associated with either ethnicity or obesity. MF, as 
measured by RQ (iAUC) was independently associated with obesity but not insulin 
resistance in Chinese, Asian-Indians and Malays. In Malays, ISI was associated with 
RQ (iAUC) but the association was completely attenuated by adjustment for obesity. 
The relationship between MF and obesity is modulated by ethnicity. In lean 
individuals, Chinese had lower MF than Malays and Indians.  However, in 
overweight/obese individuals, MF was similar between ethnic groups. These ethnic 
differences seem to relate to differences in the propensity to increase glycolysis, 
rather than suppression of fat oxidation, after a meal.  Thus, altered glycolysis should 
be considered when examining inter-individual differences in MF. 
5.4.1 Fasting RQ 
Several studies have demonstrated elevated fasting RQ in skeletal muscle from obese, 
and type 2 diabetic subjects compared to control subjects(132, 212). In contrast, other 
studies have reported a positive association between fasting fat oxidation and body fat 
mass(217-219). Flatt postulated that an increase in fat mass will lead to an increase in 
fat oxidation in response to a high fat diet, providing a new plateau of weight 
maintenance at a point where fat oxidation equals fat intake(220). In our study, fasting 
RQ was not significantly different between lean and overweight/obese individuals, 
which is consistent with studies showing that fasting RQ was not related to fat mass 
or percentage body fat(139, 221, 222). Studies that have examined the impact of 
ethnicity on fasting RQ have yielded conflicting results. Chitwood et al showed a 
significantly higher RQ in lean African-American women compared to lean white 
women, which could be a contributory factor to greater obesity in African Americans. 
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In contrast, no difference in resting RQ between African-Americans and Caucasians 
was observed in many studies(23, 37, 223). Similarly, in our study, fasting RQ was 
not different between ethnic groups although a trend towards higher use of 
carbohydrates as fasting energy substrate was observed in Malays, followed by Asian 
Indians and Chinese. A point to note is that fasting RQ may not be a reliable 
assessment of the capacity to switch from CHO to fat oxidation as RQ under fasting 
conditions is highly sensitive to differences in energy balance and diet composition 
within the few days preceding the measurement(224, 225). Either positive energy 
balance or high CHO intake can transiently elevate RQ(226). In addition, resting 
conditions may not exert a metabolic challenge for muscle mitochondrial to oxidize 
fat. Therefore, defects in skeletal muscle fat oxidation capacity is unlikely to be 
observed in resting conditions(227).  
5.4.2 Obesity 
Numerous studies have shown that obesity is associated with a blunted increase in RQ 
during a HEC(130, 132, 216, 228) or oral glucose tolerance test (OGTT)(229).  The 
insulin response occurring after MMTT may be affected by enteric hormones, amino 
acids from foods, gastrointestinal motility, neural impulses during ingestion of foods, 
and gastric emptying time, besides glucose obtained from CHO.  As such, we believe 
the MMTT represents a more physiological test that the HEC, that is performed at 
supra-physiological levels of insulin, or the OGTT where only pure glucose is 
administered for the stimulation of insulin secretion.  A few have studied MF using a 
mixed meal tolerance test (MMTT). Blaak et al showed that postprandial fat oxidation 
after a high fat meal decreased with increasing BMI(217). Huffman et al 
demonstrated that three months of caloric restriction significantly increased the 
fasting to postprandial difference in circulating acylcarnitines and free-fatty acids 
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after MMTT, indicating greater suppression of fat oxidation(230). In our study, we 
found that postprandial switch from fat to CHO oxidation was negatively associated 
with BMI and body fat %, which is in line with the findings of these studies. In 
contrast, Weyer et al have reported similar MF in obese and lean individuals exposed 
to high CHO diet(231). However, in this study (Weyer et al), MF was measured as the 
24 hour RQ after 48 hours of overfeeding with a high CHO diet.  It is not clear if 
these findings are directly comparable to ours, and those of Blaak et al and Huffman 
et al, which examine acute changes after a single meal during the fasting to the fed 
transition. 
 
5.4.3 Insulin resistance 
The lack of association between ISI and MF is not surprising.  Several studies have 
reported that metabolic inflexibility in T2D subjects assessed by HEC is not due to a 
primary impairment in glucose oxidation in muscle, but can be explained fully by 
impaired glucose uptake(134, 214, 232). In one of these studies, they reported that 
metabolically inflexible subjects had similar metabolic characteristics but higher BMI 
compared with the flexible subjects(134), which is very much in line with our finding 
that obesity rather than insulin sensitivity is a determinant of MF.  Kelley and 
Mandarino showed that insulin stimulated leg glucose oxidation was not significantly 
different between T2D subjects and controls after matching leg glucose uptake(214). 
Galgani et al also reported that the lower ∆RQ observed in T2D versus nondiabetic 
individuals, during hyperinsulinemic conditions was no longer significant after 




The relationship between MF and obesity is modulated by ethnicity. A larger RQ 
(iAUC) was observed amongst lean Asian Indians and Malays compared with 
Chinese indicating a greater propensity to oxidize glucose, relative to fat, in these 
ethnic groups during the fasting to fed transition. In overweight and obese individuals, 
the differences in RQ (iAUC) between ethnic groups were no longer seen. The 
metabolomics profile provides some insight regarding these findings.  Our data 
supports the hypothesis that the determinants of MF may differ in different ethnic 
groups.  In Chinese, increase in MF primarily correlates with the decrease in even 
chain acylcarnitines, which indicates a reduction in fatty acid oxidation, during the 
fasting to fed transition. In Indians, MF is associated with higher levels of pyruvate 
and lactate.  Higher pyruvate levels may enhance flow of glucose derived pyruvate 
carbon into the TCA cycle via pyruvate dehydrogenase, leading to increase RQ.  
Thus, we interpret this as an increase in glycolysis and glucose oxidation leading to an 
increase in RQ.  In Malays, changes in both fatty acid and glucose oxidation are 
implicated in MF.  In response to MMTT, a greater increase in pyruvate and lactate, 
were seen in lean Asian-Indians and Malays compared to Chinese.  
 
 We also explored the possibility that adipokine secretion may differ between 
individuals from different ethnic groups with increasing obesity and that may underlie 
the associations observed. We found a negative correlation between leptin and MF, 
which is supported by the study of Hwa et al, showing that leptin administration in 
ob/ob mice reduces RQ, an indication of a reduction in relative carbohydrate 
oxidation rate and of a rise in the fat oxidation rate(233). Human studies have shown 
that leptin stimulates skeletal muscle fatty acid oxidation through the 5’-AMP-
activated protein kinase (AMPK) pathway(234). Wauters et al demonstrated that 
polymorphisms in the leptin receptor gene are associated with relative fat oxidation 
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rates in response to a glucose load(235). Furthermore, adjustment for leptin attenuated 
the association between obesity and MF such that the no statistically association 
between BMI and RQ(iAUC) was observed after this adjustment.  This suggests that a 
large portion of the association between obesity and MF could potentially be 
mediated by the actions of leptin. 
Previous studies have reported ethnic differences in the associations between leptin 
and obesity(236, 237). Moriomoto et al recently showed that higher levels of leptin 
with greater BMI was most prominent in African American, followed by White, 
Latino, Native Hawaiians and Japanese American women(236). In our study, Chinese 
show less of an increase in leptin with increasing obesity compared to Malays, with 
the interaction reaching statistical significance for %body fat. Also, the magnitude of 
the association between leptin and MF is also smaller in Chinese compared to Asian-
Indians and Malays although this did not reach statistical significance. Thus, with 
increasing obesity, the increase in plasma leptin is less in Chinese than in Malays, and 
this may be the reason that the association between obesity and MF is less 
pronounced in Chinese than in Malays.  
In our study, adiponectin was not associated with MF, which opposes previous 
findings(216, 238). Sparks et al reported higher fasting adiponectin levels was 
associated with greater insulin stimulated glucose uptake and oxidation in healthy 
young males(216). Asterholm also demonstrated adiponectin improved MF in mice 
exposed to chronic high fat diet feeding by enhancing clearance of circulating fatty 
acids and mitochondrial density in adipocytes(238). 
We considered several possible reasons as to why lean Chinese are less efficient in 
switching from fat to CHO utilization than their Asian-Indian and Malay counterparts. 
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Studies have reported regional variations in the lipolytic activity of human adipose 
tissue where the rate of lipolysis is lowest in the subcutaneous region and highest in 
the visceral region. The lipolytic β1, β2 and β3 adrenoceptors are most active in the 
visceral fat cells and antilipolytic insulin receptors, α2 adrenoceptors and adenosine 
receptors are most active in the subcutaneous fat cells(239). In our study, VSR is 
higher in lean Chinese than the other ethnic groups, suggesting that the adipose tissue 
exhibit increased lipolysis and reduced insulin mediated antilipolysis, leading to 
higher circulating FFA. Higher plasma FFA may increase lipid oxidation and in turn 
reduce insulin stimulated glucose uptake and oxidation(216, 240). Although we did 
not find differences in plasma non-esterified fatty acids (NEFA) between ethnic 
groups during fasting (Chinese (0.48±0.19), Asian-Indians (0.56± 0.26), Malays 
(0.49± 0.27)) and postprandial conditions (Chinese (0.12±0.058), Asian-Indians 
(0.12± 0.063), Malays (0.15± 0.091)), differences in NEFA turnover rates or NEFA 
availability may have been present. Secondly, adipose tissue lipid storage capacity 
may impact MF. We postulate that Chinese may have a lower capacity for fat storage 
and is less able to buffer the influx of dietary fat entering the circulating in the 
postprandial period and prevent excess exposure of peripheral tissues to fatty acids.  
5.4.5 Clinical Implications  
In lean Asian-Indians and Malays, greater suppression of fat oxidation after a mixed 
meal creates a metabolic profile favoring fat storage. These individuals may be less 
able to switch on fat oxidation in response to an increase in dietary fat intake, and 
they may therefore be prone to store fat as adipose leading to a partitioning of energy 
toward fat mass at the expense of lean mass. Moreover, previous studies have 
suggested that greater CHO oxidation and lesser fat oxidation may predispose certain 
individuals to store less glycogen and therefore experience more hunger. This 
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increased hunger may lead to ingestion of more total energy leading to chronic 
positive energy imbalance and gain in body fat (46, 241). Eckel et al reported that 
individuals with increased CHO balance at the end of a 15-day high-CHO diet gained 
less body weight and fat mass over the next 4 years than those with lower CHO 
balance(242). Zurlo et al have also shown high 24-h RQ (high ratio of CHO to fat 
oxidation) to be a predisposing risk factor for fat mass gain, independent of energy 
expenditure(7). As such, higher rates of CHO relative to fat oxidation in lean Asian-
Indians and Malays compared to lean Chinese, may predispose them to deplete 
glycogen stores and ingest more total energy. Data from the National Health Survey 
2010 supports this and have shown that obesity prevalence is highest in Malays 
(24.0%) followed by Asian-Indians (16.9%) and Chinese (7.9%). Another implication 
of lower CHO oxidation in lean Chinese is increased de novo lipogenesis (DNL) of 
excess dietary CHO in adipose tissue and liver. In our study, lean Chinese exhibit 
significantly higher hepatic fat content than their Asian-Indian and Malay 
counterparts, therefore are at a higher risk for developing non-alcoholic fatty liver 
disease. No differences in hepatic fat between ethnic groups were observed in 
overweight and obese individuals.  
5.4.6 Limitations 
Due to cross-sectional comparisons of lean and obese subjects, whether impaired MF 
is a primary defect or arises secondarily after an individual has become obese cannot 
be effectively addressed. In addition, the issue of whether lower CHO oxidation 
observed at a whole body level in lean Chinese compared to Asian-Indians and 
Malays is the consequence of reduced glucose uptake, impaired CHO oxidative 
capacity or enhanced ability to store glycogen in skeletal muscle could not be 
determined in our study. We also examined a very specific population of healthy 
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young men, hence it is impossible to extrapolate these findings to women, older 
individuals or those with T2D. In summary, the impaired capacity in switching from 
fat to CHO oxidation is associated with obesity, increased volumes of VAT, SAT and 
liver fat, an effect present primarily in Asian-Indians and Malays. Insulin resistance 
was not associated with MF after adjusting for obesity, supporting the concept that 
MF is associated with obesity per se. Serum leptin and RBP4 may mediate the 
interaction between ethnicity, obesity and MF.  
 
In summary, MF, as measured by RQ (iAUC) is associated with obesity per se and 
not with insulin resistance. Ethnicity modulates the relationship between MF and 
obesity. In lean individuals, Chinese had lower MF than Malays and Indians.  
However, in overweight/obese individuals, MF was similar between ethnic groups. 
This study provides evidence that ethnic differences should be considered when 
evaluating MF.  
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Chapter 6 : The role of skeletal muscle metabolism in resting energy expenditure 
and metabolic flexibility in Chinese and Asian-Indian men 
6.1 Introduction 
Previously, we have shown that after controlling for body weight, Asian Indians 
exhibit lower resting energy expenditure (REE) than Chinese (Chapter4). 
Furthermore, Chinese displayed lower metabolic flexibility (MF) in substrate 
switching from fat to carbohydrate oxidation in response to a mixed meal than Malays 
and Indians in lean individuals. In contrast, MF was similar between ethnic groups in 
overweight/obese individuals (Chapter 5). However, the molecular basis for ethnic 
variability in REE and MF is not known.  
 
Skeletal muscle is not only a major insulin target tissue responsible for approximately 
80% of insulin-responsive glucose uptake, it also involved in glycogen storage, lipid 
oxidation and nonshivering thermogenesis. A significant proportion of variability in 
REE after adjustment for fat-free mass (FFM) and fat mass has been shown to be 
associated with the variability in skeletal muscle metabolism(73). Mitochondrial 
proton leak, by which the potential energy in the proton motive force is dissipated as 
heat instead of being trapped in ATP, is postulated to be an important determinant of 
metabolic rate as it accounts for 20% of the basal oxygen consumption rate in 
rats(243). However, the physiological role of proton leak in humans is not fully 
understood. Adenine nucleotide translocase 1(ANT1) and uncoupling protein 3 
(UCP3) localized on the inner mitochondrial membrane are reported to mediate basal 
and inducible proton leak of mitochondria in skeletal muscle, hence are likely 
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candidates to underlie the physiological variability in REE. Transgenic mice that 
overexpress human UCP3 in skeletal muscle are hyperphagic but weigh less than their 
wild-type littermates(86). In human studies, UCP3 mRNA expression was positively 
correlated with REE adjusted for fat-free mass and fat mass (119).  
 
Given the prominent role of skeletal muscle in substrate selection, muscle 
mitochondrial function is likely to have a prominent role in MF. However the link 
between mitochondrial function and MF remains controversial. Myotubes from lean 
subjects exhibit increased mitochondrial respiration (state 3) in the presence of 
palmitoyl carnitine compared to obese subjects, indicating that skeletal muscle of 
obese individuals inherently lacks metabolic flexibility (145). In contrast, studies have 
also reported that defective insulin-stimulated glucose disposal rate is the main 
determinant of metabolic inflexibility suggesting that MF is merely a consequence of 
insulin resistance in obesity and type 2 diabetes (T2D)  
 
The purpose of this study was to investigate potential inter-individual differences in 
skeletal muscle characteristics that can explain variability in REE and MF and also 
the impact of ethnicity on molecular factors affecting skeletal muscle energy 
metabolism. Before answering these questions, we want to establish whether primary 
human myoblast or myotube is a better in vitro experimental model for the study of 





6.2 Materials and methods 
6.2.1 Subjects 
We selected myoblasts from 12 Chinese subjects (4 lean and 8 overweight/obese) and 
11 Asian-Indian (5 lean and 6 overweight/obese). Subject details are described in 
Section 2.2.  
6.2.2 Anthropometry and body composition measurement  
Body weight and height were measured as previously described in Section 2.3. Body 
composition was measured by dual-energy x-ray absorptiometry (DEXA; Hologic 
Discovery Wi) as previously described in Section 2.3.  
6.2.3 Measurements of resting energy expenditure and respiratory quotient  
Open-circuit indirect calorimetry was performed in the early morning after a 10-hour 
overnight fast.  Subjects were also asked to refrain from intensive physical activity 24 
h prior to measurement. Measurements of oxygen consumption (VO2) and carbon 
dioxide production (VCO2) were performed using a ventilated hood system (Quark 
CPET, COSMED, Italy) for 1-hour in the fasting condition as previously described. 
Measurements of VO2 and VCO2 were continuously measured for a further 3 hours 
following a mixed-meal tolerance test (MMTT). RQ was calculated from VO2 and 
VCO2 as follows: RQ=VCO2/VO2. Whole body MF was calculated as the incremental 
area under the curve (iAUC) for RQ (136) 
 
6.2.4 Muscle Biopsies 
Percutaneous muscle biopsy was obtained from the vastus lateralis under local 
anaesthesia and processed for myoblast and myotube culture as described in Section 
2.11. 
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6.2.5  Mitochondrial respiration 
Mitochondrial respiration was measured in primary human myotubes using a 
Seahorse XF24 Analyzer (Seahorse Biosciences, North Billerica, MA) as previously 
described in Section 2.12 
6.2.6 Quantification of gene expression 
mRNA gene transcripts for selected genes were examined using techniques described 
in Section 2.13 
6.2.7 Western Blot 
Quantification of protein abundance were performed using techniques described in 
Sections 2.14. 
6.2.8 Statistical Analyses 
Statistical analyses were performed using IBM SPSS Statistics for Mac Version 20.0; 
Armonk, NY: IBM Corp(196). All statistical tests were two-sided, and a P value<0.05 
was considered statistically significant. Comparisons of mitochondrial respiration, 
mRNA and protein expression levels between the lean and overweight and between 
Chinese and Asian-Indians were conducted using Kruskal-Wallis test. Correlations 
between REE with mitochondrial respiration and proteins were conduced using 





6.3.1 Anthropometry and clinical characteristics of subjects 
Subject characteristics are presented in Table 6.1. Overweight/obese Asian-Indians 
were younger and heavier than their Chinese counterparts. Similar FFM was observed 
between ethnic groups, although overweight/obese Asian-Indians had a significantly 
higher fat mass than Chinese. Fasting plasma NEFA concentrations were higher in 
overweight/obese Chinese than Asian-Indians. No differences in plasma 
concentrations of insulin and glucose were noted between ethnicities. REE was higher 
in Chinese than Asian-Indians, though no statistically significant differences were 
observed. RQ (iAUC) was significantly greater in Asian-Indians than Chinese in the 






















Table 6.1 Demographic and clinical characteristics of Chinese and Asian-Indians stratified into lean and overweight/obese groups. 
 
Mean SD Mean SD P value a Mean SD Mean SD P value b
Age 25.25 5.32 23.00 1.87 0.80 34.25 4.65 26.83 5.53 0.05
BMI 20.96 1.09 20.55 1.05 0.33 26.32 1.60 28.75 1.81 0.02
Total Fat Mass 9.21 4.29 8.58 2.59 0.81 19.19 5.67 28.10 6.38 0.01
Total FFM 52.57 3.76 49.93 2.62 0.22 57.53 5.95 57.93 7.60 0.70
Glucose 4.35 0.21 4.30 0.34 0.62 4.82 0.37 4.39 0.33 0.06
Insulin 6.28 2.74 9.84 10.78 0.90 12.91 6.06 19.42 8.46 0.12
NEFA 0.46 0.31 0.35 0.23 0.72 0.51 0.15 0.32 0.14 0.04
REE 1624 226 1463 94 0.33 1706 205 1620 234 0.90
Fasting RQ 0.82 0.07 0.82 0.05 0.87 0.81 0.03 0.82 0.05 0.80
RQ (iAUC) 0.002 0.012 0.028 0.013 0.01 -0.019 0.026 -0.017 0.044 0.85
a P value for comparison between ethnic groups in lean individuals
b P balue for comparison between ethnic groups in overweight and obese individuals
Lean (N=9) Overweight and obese (N=14)
Chinese (N=4)
Asian-Indian 
(N=5) Chinese (N=8) Asian-Indian (N=6)
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6.3.2 Comparison of metabolic characteristics in primary human 
myoblast and myotubes 
When visualised microscopically, primary human myoblasts were 
mononucleated (Figure 6.1). The myotubes at day 7 of differentiation appear 
multi-nucleated, elongated, with a fiber like structure, showing that fusion and 
differentiation of myoblasts into myotubes has occurred. To verify that 
primary human myoblast were fully matured into multinucleated myotubes, 
gene expression of myogenic markers of differentiation were measured in 
myotubes at days 0, 4, 8 and 12 of differentiation (Figure 6.2). MyoD is a 
member of the family of myogenic regulatory factor involved in the 
commitment of myoblast cells to differentiation. MyoD mRNA expression 
was highest at day 4, followed by a reduction at day 8 of differentiation, which 
is consistent with studies showing that MyoD is upregulated in the early stages 
of myogenesis (Figure 6.2A). The final stage of differentiation can be 
identified by the expression of the structural proteins such as α-sarcomeric 
actin and myosin heavy chain (MHC) that form part of the contractile 
apparatus. The expression of myosin heavy chain was shown to be highest at 
day 8 of differentiation but later decreased at day 12 (Figure 6.2B). Longer 
durations of differentiation may lead to myotube detachment and subsequent 








Figure 6.1 Phase contrast appearance of human satellite cell culture. 
Morphological appearance was investigated by phase contrast 
microscopy. (A) Mono nucleated myoblast cells under proliferation (10X). 



















Figure 6.2 Gene expression of myogenic markers of differentiation in 
primary human myoblast cultures from during day 0, day 4, day 8 and 
day 12 of differentiation.  
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High resolution respirometry was also performed in myoblasts and myotubes. 
In Figure 6.3, both myoblasts and myotube cultures were able to respond 
maximally to the different compounds added to the assay medium, showing 
that different parameters of mitochondrial respiration can be measured in both 
in vitro cell culture models. Next we measured the gene expression of 
uncoupling proteins UCP2, UCP3 which are major determinants of energy 
metabolism. UCP2 and UCP3 were upregulated in the myotubes at day 4 and 
day 8 of differentiation (Figure 6.4). Therefore, myotubes is a better in vitro 
experimental model for the study of energy metabolism and uncoupling 


















































Figure 6.3 Mitochondrial bioenergetic profile in primary human 


















Figure 6.4 Gene expression of uncoupling proteins in primary human 
















































(0.8 uM) Rotenone & Antimycin 
(1 uM each) 
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6.3.2 Expression of genes in TCA cycle, OXPHOS and uncoupling in 
Chinese and Asian-Indian myotubes 
Expression of oxidative and lipid oxidation genes in primary human myotubes 
is shown in Figure 6.5. The expression of peroxisome proliferator-activated 
receptor gamma coactivator-1α (PGC1A) was 2.18 fold greater (P=0.077) in 
lean Asian-Indians than lean Chinese, and 2.28 fold greater (P=0.02) in 
overweight/obese Asian-Indians than overweight/obese Chinese. There was no 
significant effect of obesity or ethnicity on expression of isocitrate 
dehydrogenase (IDH3G) involved in TCA cycle. NADH dehydrogenase 
(NDUFB4) and cytochrome c oxidase (COX15) involved in electron transport 
chain (ETC), ATP synthase (ATP5J2) involved in OXPHOS, carnitine 








































Figure 6.5 Expression of metabolic genes involved in fatty acid oxidation, 
oxidative phosphorylation and TCA cycle in Chinese and Asian-Indian 
myotubes, stratified into lean and overweight/obese groups. Data are 





6.3.3 Protein expression in Chinese and Asian-Indian myotubes 
Asian-Indians exhibited significantly higher protein levels of uncoupling 
protein (UCP3) and adenine nucleotide translocase (ANT1) involved in proton 
leak and citrate synthase (CS) involved in TCA cycle than Chinese, in both 
lean and overweight/obese states (Figure 6.6 and 6.7). Protein levels of 
cytochrome c oxidase (COXIV) were not significantly different between 






Figure 6.6 Western blots of citrate synthase (CS), cytochrome c oxidase 
(COX IV), adenine nucleotide translocase 1 (ANT1), uncoupling protein 3 
(UCP3) and GAPDH proteins in Chinese and Asian Indian myotubes of, 





























Figure 6.7 Densitometric analysis of citrate synthase (CS), cytochrome c 
oxidase (COXIV), adenine nucleotide translocase (ANT1) and uncoupling 
protein (UCP3) protein levels in primary human myotubes of Chinese 
and Asian Indians, stratified into lean and overweight/obese groups. 
Graph displays mean ± SD in arbitrary units (AU), normalized against 






6.3.4 Mitochondrial respiration in Chinese and Asian-Indian myotubes 
Proton leak and ATP turnover was not significantly associated with obesity or 
ethnicity (Figure 6.8). Upon stratification into lean and overweight/obese 
groups, we observed a trend of greater maximal respiration (178.27 ± 86.82 
vs. 110.08 ± 28.72, P=0.086) and spare respiratory capacity (123.41±83.87 vs. 
63.95 ± 28.24, P=0.086) in lean Asian-Indians than Chinese, while no 
differences were observed in the overweight/obese state. Within the Asian 
Indians, there was a trend of higher basal respiration in lean compared to 
overweight/obese individuals (54.86 ± 14.79 vs. 42.70 ± 6.31, P=0.068). 
Maximal respiration was significantly greater in lean Asian-Indians compared 















































Figure 6.8 Parameters of mitochondria respiration in Chinese and Asian-
Indians  myotubes stratified into lean and overweight/obese groups. Data 







































































































































6.3.5 Correlations between residual resting energy expenditure and 
skeletal muscle characteristics in Chinese and Asian-Indian myotubes 
Figure 6.9 shows the relationships between residual REE (difference between 
REE measured and REE predicted on the basis of FFM and fat mass) with 
mitochondrial respiration parameters. No significant associations were 
observed between residual REE with any of the mitochondrial function 
parameters in Chinese and Asian-Indians (Figure 4). Given the putative role of 
uncoupling proteins UCP3 and adenine nucleotide translocase (ANT1) in 
thermogenesis, it was interesting to examine their protein levels in relationship 
to energy expenditure. Residual REE did not correlate significantly with 
UCP3 protein levels and ANT1 protein levels in Chinese and Asian-Indians 



































Figure 6.9 Relationships between residual resting energy expenditure 
(difference between resting energy expenditure measured and resting 
energy expenditure predicted on the basis of fat-free mass and fat mass) 





























) Chinese:  r= -0.001, P= 0.997Asian-Indian: r = 0.33, P= 0.322
Basal respiration (picomoles/min)


















Chinese:  - 0.278, P= 0.381
Asian-Indian: r= 0.305, P= 0.362



















Chinese: r= 0.313, P=0.322
Asian-Indian: r = 0.225, P= 506




















Asian-Indian: r= 0.336, P=0.201
Chinese: r= - 0.267, P= 0.983


















Chinese  r = - 0.3, P=0.897
Asian-Indian : r = 0.3, P=0.142




































Figure 6.10 Relationships between residual resting energy expenditure 
(difference between resting energy expenditure measured and resting 
energy expenditure predicted on the basis of fat-free mass and fat mass) 
with uncoupling protein (UCP3) and adenine nucleotide translocase 
(ANT1) protein levels in Chinese and Asian Indian myotubes 
 

















ANT1 protein expression (AU)
Chinese: r= -0.427, P= 0.291































UCP3 protein expression (AU)
Asian-Indian: r= -0.387, P=0.344
















6.3.6 Correlations between metabolic flexibility and mitochondrial 
respiration in Chinese and Asian-Indian myotubes 
In Figure 6.11, RQ (iAUC) positively correlated with proton leak in Asian-
Indians (r=0.648, P=0.043) but not Chinese (r=0.049, P=0.88), maximal 
respiration in Asian-Indians (r=0.794, P=0.006) but not Chinese (r= -0.231, 
P=0.471) and spare respiratory capacity in Asian-Indians (r=0.697, P=0.025) 






















Figure 6.11 Relationships between RQ (iAUC) and mitochondrial 
respiration parameters in Chinese and Asian Indian myotubes. 
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6.4 Discussion 
We demonstrate that primary human myotube is a better in vitro experimental 
model than myoblast for studying energy metabolism and the regulation of 
UCPs. We report four main findings from this study: 1) REE adjusted for fat-
free mass and fat mass did not significantly correlate with mitochondrial 
function; 2) RQ (iAUC) positively correlated with basal and maximal 
respiration in Asian-Indians but not in Chinese, 3) Asian-Indians had greater 
skeletal muscle expression of oxidative and uncoupling proteins (UCP3, 
ANT1 and citrate synthase) and greater mRNA level of PGC1A, the key 
transcriptional regulator of mitochondrial biogenesis and oxidative 
phosphorylation than Chinese, irrespective of their obesity status; 2) Asian-
Indians had greater mitochondrial maximal respiration and spare respiratory 
capacity than Chinese only in lean but not overweight/obese individuals. 
Collectively these data indicate that greater mitochondrial oxidative capacity 
in lean Asian-Indians compared to Chinese may explain the greater MF 
observed in the former.  
 6.4.1 Primary human myotube: an in-vitro model for studying energy 
metabolism 
We demonstrate that primary human myotube is a better in vitro experimental 
model than myoblast for studying energy metabolism and the regulation of 
UCPs due to upregulation of UCP2 and UCP3 in myotubes compared to 
myotubes. Our results are consistent with earlier studies that showed that 
C2C12 mouse and L6 rat myoblast cell lines expressed extremely low levels 
of UCP3. Detectable levels of UCP3 were present only when the cells were 
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differentiated and acquired a myotube phenotype as the UCP3 promoter 
activity is dependent on MyoD, the myogenic determining factor(244). Human 
primary myotubes is a widely used in vitro model system to study energy 
metabolism under standardized conditions and metabolic disorders as human 
primary muscle cells express traits known from in vivo muscles. Another 
advantage is that the extracellular environment can be controlled precisely and 
kept constant over time, which allows the studying of genetic and epigenetic 
influences without systemic homeostatic regulatory components from the 
nervous and endocrine environment(142, 245, 246).  Insulin resistance in 
skeletal muscle in vivo is associated with reduced lipid oxidation and lipid 
accumulation. According to Gaster et al, myotubes established from type 2 
diabetic subjects expressed reduced palmitic acid oxidation, basal glucose 
uptake and insulin-stimulated glycogen synthase activity compared with 
control myotubes, which suggest that the diabetic phenotype might be intrinsic 
to the muscle cells themselves and is conserved in vitro by either genetic, 
epigenetic factors(247, 248). Boyle and colleagues demonstrated that 
myotubes from lean subjects has increased mitochondrial respiration (state 3) 
in the presence of palmitoyl carnitine compared to obese subjects, indicating 
that skeletal muscle of obese individuals inherently lacks metabolic 
inflexibility in response to lipid exposure(145). Therefore, this in vitro model 
provides an experimental system enabling us to study potential intrinsic 
mechanisms to the skeletal muscle that may explain variability in energy 
expenditure and metabolic flexibility.   
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6.4.2 Relationship between skeletal muscle metabolism and resting energy 
expenditure  
This study shows that the remaining variability in REE after adjustment for 
FFM and fat mass cannot be explained by variation in mitochondrial function, 
in particular proton leak. Our data does not support the study of Rolfe and 
Brand who reported that proton leak in the skeletal muscle is a significant 
contributor, accounting for 17-21% of REE in rodents(243). In humans, 
studies have reported the link between proton leak and adaptive 
thermogenesis. Wijers and colleagues showed that in lean male subjects, 50% 
of the variability in nonshivering thermogenesis upon mild cold exposure 
(16°C) could be explained by mitochondrial proton leak in permeabilized 
muscle fibers. In a study by Lebon and colleagues, infusion of 
triiodothyronine (T3), a known factor involved in thermogenesis, in human 
subjects increased TCA flux in combination with unchanged ATP synthesis, 
indicative of increased mitochondrial proton leak (249). These data suggests 
that in humans, skeletal muscle may be more important in regulating adaptive 
thermogenesis rather than resting energy metabolism. Indeed, the muscle 
tissue can only account for 20-30% of total resting oxygen uptake, however it 
can account for up to 40-50% increase in whole body oxygen uptake after 
epinephrine or ephedrine infusion(72). High metabolic rate organs (brain, 
kidney, heart and liver) contribute a disproportionately larger fraction of REE 
than their fractional volume of the body compared to the muscle. Thus the 
pathways contributing to the metabolic rate of these organs may be of more 
relevance to the study of REE. In addition, other ATP consuming processes 
such as protein turnover, ion cycling across plasma membranes (Ca2+ and 
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Na+/K+ ATPase) and substrate cycling that were not examined in this study, 
could contribute to variation in REE. Another possibility is that myotube 
cultures may not be a suitable in vitro experimental model for the study of 
energy metabolism. The drawback of cell cultures in general is that cells 
change their phenotype, which may alter the expression of certain genes and 
compromise the phenotypic expression of the disease. Indeed, the comparison 
of transcriptome between human myotubes and skeletal muscle tissue revealed 
a significant downregulation of genes involved in key metabolic pathways 
such as energy metabolism (UCP3), oxidative phosphorylation (complex I, II, 
III and IV), fatty acid oxidation (CPT1B) and glycolysis(250).  
 
We also showed that protein level of UCP3 was not correlated with REE, 
inconsistent with the concept of a thermogenic role for uncoupling proteins. 
Schrauwen et al reported that in Pima Indians, UCP3 mRNA positively 
correlated with REE, indicating that UCP3 may be a determinant of energy 
expenditure(119). However, the question of whether the relationship was also 
observed at the protein abundance or activity level was not addressed. Our 
finding is consistent with many other studies reporting the lack of association 
between UCPs and REE. Bao and colleagues reported that UCP2 and UCP3 
mRNA levels were not correlated with REE in adults(127). Yanovski et al also 
found no significant association between UCP2 genotype and REE in 
children(251). After 10 weeks of weight loss on low caloric diet in T2D 
subjects, diet induced changes in UCP3 protein was not significantly 
correlated with REE, but was associated with changes in skeletal muscle fatty-
acid binding protein content, suggesting a role of UCPs in fatty acid 
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metabolism rather than regulation of energy expenditure(252). Significant 
increases in UCP2 and UCP3 gene expression are observed during fasting and 
severe food restriction, conditions in which metabolic rate decreases(253). 
Boss et al. (26) have detected a significant positive correlation between UCP3 
mRNA and circulating free fatty acids in human muscle from obese patients. 
We also examined the association between ANT1 protein and REE but 
observed no significant associations. Brand and colleagues reported that the 
adenine nucleotide carrier catalyzed half to two-thirds of the basal proton 
conductance of Drosophila mitochondria and may be an important contributor 
to metabolic rate(103). However, ANT1 may have a greater role in catalyzing 
ADP–ATP exchange rather than proton leak. In humans, mutations in the 
heart and muscle isoform of ANT1 were found to be associated with 
autosomal-dominant progressive external opthalmoplegia (adPEO) clinically 
characterized by increased serum lactate, exercise intolerance, ptosis and 
muscle weakness. Muscle biopsies show over proliferation of mitochondria 
and mild reduction of oxidative phosphorylation enzymes(254). Mielke et al 
recently reported that acetylation of ANT1 in vivo in human skeletal muscle 
was associated with decreased ADP affinity, altered OXPHOS and insulin 
sensitivity(255).  
 
Furthermore, we observed higher UCP3 protein levels in Asian-Indians than 
Chinese, which is counterintuitive since Asian-Indians have lower REE. To 
our knowledge, only one study has examined the contribution of UCP3 to 
ethnic differences in REE. Kimm et al associated a UCP3 exon 5 
polymorphism with significantly lower REE in African American women with 
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the CC genotype than in those with the TT genotype, while this effect was 
absent in White women, thereby suggesting that this variant is responsible for 
the lower REE observed in African Americans.  However, nothing is known 
about the effect of the exon 5 variant on UCP3 protein levels or function. The 
implications of higher UCP3 in Asian-Indians are not exactly known, however 
we postulate that upregulation of UCP3 may be a compensatory mechanism to 
reduce reactive oxygen species (ROS) and protect cells from oxidative 
damage to prevent the greater development of insulin resistance.  We have 
shown that within Asia, Asian-Indians exhibit the greatest insulin resistance 
and Chinese the least. Our hypothesis is supported by the study of Aguer and 
colleagues who demonstrated that myotubes from obese non-diabetic subjects 
with a family history of T2D have increased proton leak, lower ROS and 
similar oxidative stress level compared to obese non-diabetic subjects without 
a family history of T2D. 
6.4.3 Relationship between skeletal muscle metabolism and metabolic 
flexibility  
 
MF was positively associated with mitochondrial basal respiration and FCCP 
induced maximal respiration which is consistent with previous studies. 
Maximal respiration reflects the maximal mitochondrial oxidative capacity of 
the electron transport chain and the upstream substrate translocases and 
dehydrogenases and is referred to as maximal uncontrolled mitochondrial 
oxidative capacity(168). Phielix et al reported that the rate of PCr resynthesis 
(ie halftime of recovery), which reflects in vivo mitochondrial oxidative 
capacity or function was associated with insulin stimulated glucose oxidation 
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and MF. Subjects with a family history of T2D had an impaired ability to 
increase fatty acid oxidation in response to high fat meal and this was 
associated with impaired activation of genes involved in oxidative and lipid 
metabolism such as peroxisome proliferator-activated receptor coactivator-1α
(PGC1A) and fatty acid translocase (FAT/CD36)(137) Metabolic switching 
represented by dynamic changes in fat oxidation in primary human myotubes 
mirror the MF phenotype of the cells’ donor, supporting the hypothesis that 
MF is an intrinsic characteristic of skeletal muscle. In contrast, Wijers et al 
found that in vivo mitochondrial capacity was related to basal RQ but not MF, 
suggesting that reduced mitochondrial function does not negatively impact the 
ability of skeletal muscle to switch substrates, rather it is primarily responsible 
for basal substrate utilization. Gaster and colleagues reported that suppression 
of glucose oxidation in response to palmitate in the presence of insulin was 
similar in myotubes established from lean, obese, and type 2 diabetic donors, 
indicating that metabolic inflexibility is not an intrinsic defect in skeletal 
muscle, but based the inability to vary extracellular fatty acid concentrations 
during insulin stimulation(146). 
 
Lean Asian-Indians had higher skeletal muscle mitochondrial OXPHOS 
capacity as demonstrated by higher mitochondrial maximal respiration, higher 
protein abundance of citrate synthase and mRNA of PGC1A compared to their 
Chinese counterparts. Our results are consistent with those of Nair and 
colleagues who reported that Asian-Indians had increased skeletal muscle 
capacity for OXPHOS and mitochondrial DNA copy number than Northern 
European Americans(256). Hall et al also showed that South-Asians exhibited 
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greater oxidative and lipid metabolism capacity compared to Europeans(257). 
The potential implication of a higher oxidative capacity on energy metabolism 
in lean Asian-Indians is not clear at this time, however we postulate that it 
promotes a metabolic shift towards increased glucose oxidation in muscle, 
contributing to greater MF observed in Asian-Indians.  
 
In summary, these data indicate that lower REE in Asian-Indians than Chinese 
is not the consequence of higher skeletal muscle expression of UCP3 in Asian-
Indians. Skeletal muscle may not have the intrinsic capacity for regulating 
resting energy metabolism via mitochondrial proton leak. Greater maximal 
respiration in lean Asian-Indians than Chinese could explain the greater MF 





Chapter 7 . Characterization of fat mass and obesity associated (FTO) 
gene in skeletal muscle energy and nutrient metabolism and its epigenetic 
link to obesity 
7.1 Introduction 
Several single nucleotide polymorphisms (SNPs) that cluster in the first intron 
of fat mass and obesity associated (FTO) gene are associated with obesity in 
genome-wide association studies (GWAS). Human studies to date suggest that 
the association between SNPs in FTO and BMI is predominantly driven by 
increased energy intake, but not energy expenditure(258-260). Individuals 
homozygous for the obesity-risk allele exhibit greater ad libitum food 
intake(261), particularly dietary fat consumption(262), increased appetite and 
reduced satiety(263), poor food choices(264) and eating habits and loss of 
control over eating(265) than those homozygous for non-risk allele. Evidence 
from rodent studies suggests that FTO is nutritionally regulated and can 
influence food intake, which is consistent with human studies. FTO mRNA 
and protein levels are downregulated by essential amino acid deprivation in 
mouse cell lines(266). Within the arcuate nucleus of the hypothalamus, 48-h 
fasting reduced FTO expression, whereas prolonged exposure to high fat diet 
increased FTO expression(267). In addition, selective alteration of FTO levels 
in the arcuate nucleus influenced food intake(171). FTO is ubiquitously 
expressed across multiple tissues, but is most highly expressed in brain, 




Recently, several animal studies have shown the effect of FTO on body weight 
regulation and energy expenditure, suggesting the peripheral role of FTO in 
energy homeostasis(158, 159). FTO null mice exhibit significant reduction in 
adipose tissue and a decreased propensity to gain weight on a high-fat diet 
(HFD), compared with their wild-type littermates. The lean phenotype 
developed as a consequence of increased energy expenditure and systemic 
sympathetic activation, despite decreased physical activity and 
hyperphagia(158). Mice with a missense loss of function mutation (I367F) in 
FTO also displayed a lean phenotype with an increased metabolic rate but no 
change in physical activity or food intake(159). However to date, the 
molecular mechanisms by which FTO regulates energy metabolism in human 
skeletal muscle remains to be elucidated.  
 
The disadvantage of using genetic approaches, such as gene deletion/ gene 
silencing and lost-of-function mutations is that they may not accurately reflect 
the actual physiological conditions(171). Knockout of the FTO gene in animal 
model frequently results in severely compromised organism, which is 
associated with increased postnatal death and growth retardation(158). This, 
however, is not observed in human population carrying the FTO risk alleles. 
Human SNPs involve an impairment of function, rather than a complete loss 
of function. In addition, genetic manipulation may also result in altered 
expression of other genes in the same genomic region through long range 
interactions, such as IRX3 and, potentially, other genes.  
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To overcome these limitations, we propose using a chemical probe approach, 
where small molecule that selectively inhibits FTO demethylase activity will 
be used to dissect the molecular mechanisms of FTO. The chemical probe 
approach is complementary to, and has advantages over genetic methods, as it 
would allow a temporary, dose-dependent reduction of FTO catalytic activity, 
without affecting other potential biological functions of FTO. 
 
FTO is a Fe (II) and 2-oxoglutarate (2OG) dependent demethylase, 
homologous with the E.coli DNA repair protein AlkB and the mammalian 
homologues ALKBH2 and ALKBH3(267). In vitro, recombinant FTO 
catalyzes the oxidative demethylation of 3-methylthymine in single-stranded 
DNA, 3-methyluracil in RNA(267, 268) and N6-methyladenine (m6A)(269) 
in RNA, suggesting a physiological role for FTO in nucleic acid repair or 
modification. Of special interest is the m6A modification, which is one of the 
most common and abundant post-transcriptional modification in mRNA. It has 
been identified in more than 7000 genes in human, where it is enriched near 
stop codons and in the 3’-UTR of mRNA, hence suggesting a possible 
involvement in the regulation of gene expression(270). This modification has 
also been suggested to affect RNA processing, RNA transport and translation 
efficiency(271). However, it is unclear if and how the m6A demethylation 
activity of FTO is linked to human obesity.  
 
The aim of this study is to characterize the function of FTO in skeletal muscle 
metabolism and examine how the N6-methyladenosine (m6A) demethylation 
activity of FTO contributes to its metabolic effects and obesity using two 
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approaches a) genetic approach by gene silencing and b) chemical probe 
approach using a novel pharmacologic inhibitor (CA) of FTO catalytic 
activity. We will be focusing on 4 metabolic pathways : 1) Energy 
metabolism, 2) fatty acid metabolism (β-oxidation and de novo lipogenesis), 




7.2 Material and methods 
7.2.1 Subjects 
Primary human myoblast were initiated from satellite cells of vastus lateralis 
obtained from 4 healthy lean Chinese men with normal insulin sensitivity, 
FPG <7.0 mmol/L and no prior history of T2DM. Subject details are described 
in Section 2.2 
7.2.2 Discovery of potent and subfamily-selective small molecule probe of 
FTO 
 
Prior to this study, there was no report of small molecule that is able to 
selectively inhibit the demethylase activity of FTO. Prof Esther Woon’s lab 
embarked on a probe discovery programme, where they employed an 
innovative drug discovery strategy called Dynamic Combinatorial Mass-
Spectrometry (DCMS)(272). This technique uses a self-assembly process to 
spontaneously generate a dynamic library of chemical compounds. 
Compounds that fit best into the catalytic site of FTO will be preferentially 
formed and be detected by Protein Mass-Spectrometry. This method led to the 
first discovery of several promising FTO inhibitors, which has been 
successfully patented. One inhibitor in particular, CA, satisfies all the 
important requirements for use as a FTO functional probe : 1) CA is able to 
inhibit the m6A demethylase activity of FTO (IC50 = 0.8µM), 2) CA is highly 
selective for FTO against other structurally similar proteins and exhibits 30-
fold to 130-fold selectivity for FTO over structurally related subfamily 
members such as AlkB, ALKBH2, ALKBH3 and ALKBH5; 3) CA is active 
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in cells, with low cytotoxicity. MTT assay with HeLa cells showed that >80% 
of the cells remain viable after treatment with 100M of CA and HeLa cells 
that were treated with CA showed a significant increase in the level of m6A 















7.2.3 MTT assay 
Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay (Sigma). Primary human myoblasts 
were seeded at a concentration of 5 X 104 cells/ml onto 96-well plates and 
were allowed to adhere overnight. After 24h, cells were treated with CA in the 
concentration range of 10 -100 µM for 72 h with untreated cells acting as 
controls. After 72 h, medium was replaced with 100 µl of 0.5 mg/ml MTT 
Figure 7.1 A crystal structure of FTO in 
complex with CA 
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each well and was incubated for another 4 h. Formazan crystals formed were 
solubilized in 10% sodium dodecyl sulfate with 0.01 M hydrochloride acid 
(100 µl) for 4 h and the absorbance was measured at 570 nM with a reference 
wavelength of 650 nM using a micro-plate reader (Multiskan Spectrum, 
ThermoElectro Corporation, Waltham, MA, USA). Cell viability (%) was 
calculated using the formula: [(Mean absorbance of the sample – reference 
absorbance)/ (Mean absorbance of the control)]  
7.2.4 Small interfering RNA (siRNA) transfection of FTO and CA 
treatment in primary human myotubes 
 
Gene silencing by siRNA was performed using siTRAN 1.0 (Origene, 
Sweden) onto cells cultured in 6-well plates. Differentiation media was 
changed to PS-free growth medium on day 2 of myotube differentiation. On 
day 3, siRNAs against FTO (5 nM) (Origene, Sweden) were transfected using 
siTRAN in serum-free DMEM (incubating time >24 hr). Myotubes were then 
washed with PBS and maintained in differentiation medium. To study the 
effects of acute and chronic exposure to CA, myotubes were treated with 50 
µM and 100 µM CA for 6 h and 24 h respectively on day 6 of differentiation. 
For insulin treatment experiments, cells were deprived of serum for 4 hours 
before stimulation with insulin (100 nM) for 30 min before harvest. Cells were 
used for experiments 6-7 days following differentiation.  
7.2.5 Quantification of mRNAs 
Total RNA samples from cell cultures were extracted as previously described 
in Section 2. mRNA levels were measured by reverse transcription followed 
by real time PCR in Section 2.13. 
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7.2.6 Western Blot 
Quantification of protein abundance were performed using techniques 
described in Sections 2.14. 
7.2.7 High resolution respirometry in CA treated myotubes 
Mitochondrial bioenergetics was measured in primary human myotubes using 
a Seahorse XF24 Analyzer (Seahorse Biosciences, North Billerica, MA) as 
previously described in Section 2.12. Myoblasts were seeded on XF24 tissue 
culture plates at 20 000 cells/well in growth medium using 6 technical 
replicates of each clinical sample and induced to differentiate into myotubes. 
At day 5 of differentiation, 50 µM CA was added for 24 h incubation. The 
next day, myotubes were incubated for 45 min at 37 °C at ambient CO2 in XF 
Assay Medium (Seahorse Biosciences) (pH 7.4) containing 4 mM glutamine, 
1 mM pyruvate and 25 mM glucose.  
7.2.8 2-deoxy-D-[3H]glucose uptake assay in CA treated myotubes with 
palmitate treatment  
Primary human myotubes were pre-incubated in serum-free DMEM for 6 h. 
Cells were then incubated in PBS + 0.2 % BSA for 30 min at followed by 
addition of 5 µM [3H]2-deoxyglucose (0.50 µCi per well), for 10 min. After 
incubation with [3H]2-deoxyglucose, medium was rapidly aspirated and cells 
washed three times with ice-cold PBS and lysed in 200 µl of RIPA buffer, of 
which 100 µl was transferred to scintillation liquid and the remaining was 
used for protein concentration using Bradford Assay. Radioactivity was 
determined by liquid scintillation counting.  
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7.2.9 Statistical Analyses 
Statistical analyses were performed using IBM SPSS Statistics for Mac 
Version 20.0; Armonk, NY: IBM Corp(196). All statistical tests were two-
sided, and a P value<0.05 was considered statistically significant. 
Comparisons of mitochondrial respiration parameters, mRNA and protein 
expression levels between FTO knockdown myotubes and controls and 
between CA treated myotubes and controls were conducted using Kruskal-
Wallis test.  
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7.3 Results 
7.3.1 FTO knockdown in human myotubes 
In FTO-deficient myotubes, FTO mRNA levels were reduced to <30% and 
FTO protein levels were reduced to <40% (Figure 7.2). Cells were viable and 






























Figure 7.2 Knockdown of FTO in primary human myotubes (A) RT-PCR 
showed decreased FTO mRNA levels in both FTO-specific siRNA 
transfections. Data are expressed as mean ±SD. *, P<0.05 (B) Reduced 
FTO protein levels were revealed by western blot in both FTO-specific 























FTO siRNA 1 (5 nM)
FTO siRNA 2 (5 nM)
* *
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7.3.2 MTT Cytotoxic Assay 
MTT assay with primary human myotubes showed that >90% of the cells 
remain viable even after treatment with high dose of CA (100 µM), showing 










Figure 7.3 Effects of CA on the viability of primary human myotubes, 
as determined by MTT cytotoxicity assay.  
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7.3.3 Gene expression in FTO knockdown primary human myotubes 
The mRNA level of uncoupling protein 3 (UCP3), involved in proton leak 
(Figure 7.4A) was significantly induced by 2.2 fold in FTO deficient 
myotubes compared with control myotubes. Carnitine palmitoyltransferase 1B 
(CPT1B) essential for β-oxidation of fatty acid was significantly upregulated 
while acetyl CoA carboxylase (ACC1) and fatty acid synthase (FASN) that 
promotes the synthesis of fatty acid were significantly downregulated (Figure 
7.4B). The expression of peroxisome proliferator-activated receptor gamma 
coactivator-1α (PGC1A), the driver of mitochondrial biogenesis and oxidative 
phosphorylation (OXPHOS), was also significantly increased in FTO-
deficient cells by approximately 2-fold (Figure 7.4C). There was no 
significant change in the expression of isocitrate dehydrogenase (IDH3G), 
which is involved in tricarboxylic acid cycle (TCA), although the expression 



























































Figure 7.4 The effects of FTO deficiency on the expression of metabolic 
genes in primary human myotubes involved in (A) energy metabolism, (B) 
fatty acid oxidation and de novo lipogenesis, (C) oxidative 
phosphorylation (OXPHOS) and TCA cycle. Data are expressed as 
expressed as mean ±SD. *, P<0.05 versus control. Abbreviations used: 
UCP3, uncoupling protein; CPT1B, carnitine palmitoyltransferase 1B; 
HADHA, hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA 
thiolase/enoyl-CoA hydratase; FASN, fatty acid synthase; ACC1, Acetyl-

























































































COX15 homolog; ATP5J2, ATP Synthase, H+ Transporting, 
Mitochondrial Fo Complex, Subunit F2; PGC1A, peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha; CS, citrate 
synthase; IDH3G, isocitrate dehydrogenase 3 (NAD+) gamma 
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7.3.4 Gene expression in FTO inhibitor (CA) treated primary human 
myotubes 
Similar to the FTO knockdown myotubes, CA treatment induced the gene 
expression of UCP3 (Figure 7.5A) and CPT1B (Figure 7.5B) at both 6h and 
24h of exposure. mRNA level of hydroxyacyl-Coenzyme A dehydrogenase 
(HADHA) involved in fatty acid oxidation increased after 6h CA treatment 
but decreased after 24 h CA treatment (Figure 7.5B). This is coupled with 
significant downregulation of genes ACC1 and FASN in a dose dependent 
manner (Figure 7.5C). OXPHOS genes such as ATP5J2 and PGC1A (Figure 
7.5D) were significantly upregulated, although a downregulation of CS was 
























































































































































































































































Figure 7.5 The effects of FTO inhibitor (CA) on the expression of 
metabolic genes in primary human myotubes involved in (A) energy 
metabolism, (B) fatty acid oxidation (C) de novo lipogenesis, (D) oxidative 
phosphorylation and (E) TCA cycle. Data are expressed as mean ±SD. *, 
P<0.05 versus control. Abbreviations used: UCP3, uncoupling protein; 
CPT1B, carnitine palmitoyltransferase 1B; HADHA, hydroxyacyl-CoA 
dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase; FASN, 
fatty acid synthase; ACC1, Acetyl-CoA Carboxylase 1; COX15, 
Cytochrome c oxidase assembly protein COX15 homolog; ATP5J2, ATP 
Synthase, H+ Transporting, Mitochondrial Fo Complex, Subunit F2; 
PGC1A, peroxisome proliferator-activated receptor gamma coactivator 



























































































































































7.3.5 Mitochondria respiration in FTO inhibitor (CA) treated primary 
human myotubes. 
To verify whether the altered expression of mitochondrial genes was 
functionally relevant, we determined mitochondrial respiration rates in CA 
treated myotubes (Figure 7.6). Treatment of myotubes with a low dose of 50 
µM CA for 24h was able to induce a maximal response in mitochondrial 
respiration in myotubes similarly to the higher doses (100µM and 200µM) 
(Figure 7.6A). A significant increase in basal respiration was observed, which 
is likely due to an increase in ATP turnover, rather than proton leak (Figure 
7.6B). There was also a marked increase in spare respiratory capacity 
implying an overall improvement in mitochondria oxidative capacity. There 























































Figure 7.6 The effects of FTO inhibitor (CA) on mitochondria 
bioenergetic profile of primary human myotubes. (A) The oxygen 
consumption rate (OCR) of human myotubes when treated with 50µM, 
100µM and 200µM CA for 24h. (B) FTO inhibition caused a significant 
increase in basal respiration and spare respiratory capacity. (*P < 0.05; 

















































































7.3.4 Glucose uptake and p-Akt signalling pathway in FTO inhibitor (CA) 
treated primary human myotubes 
We further investigated the effect of CA treatment on glucose uptake and 
insulin sensitivity. Treated human myotubes showed an increase in basal 
glucose uptake rate compared to untreated control (Figure 7.7). Remarkably, 
CA was also able to alleviate the reduction in glucose uptake caused by 
palmitate acid (PA). The effect of CA does not appear to be mediated via the 
insulin-Akt signaling pathway, as CA treatment did not significantly modify 
basal and insulin-stimulated Akt (Ser473) phosphorylation (Figure 7.8). 
Similarly, FTO deficiency in human myotubes did not significantly modify 















Figure 7.7 The effects of FTO inhibitor (CA) and palmitate (PA) on basal 
































































Figure 7.8 (A)Western blots of pAkt (Ser473) and GAPDH in FTO 
inhibitor (CA) treated myotubes under basal conditions and after insulin 
stimulation. (B) Graph showing densitometric analysis of p-Akt protein 
levels normalized against GAPDH protein levels in CA treated primary 
human myotubes *P < 0.05 versus basal situation. Data are expressed as 

























































Figure 7.9 (A) Western blots of pAkt (Ser473) and GAPDH in FTO 
deficient myotubes under basal conditions or after insulin stimulation. 
Histogram represents *P < 0.05 versus basal situation. B) Graph showing 
densitometric analysis of p-Akt protein normalized against GAPDH 
protein levels in FTO knockdown primary human myotubes. Data are 































7.3.5 m6A methylation level in FTO knockdown and FTO inhibitor (CA) 
treated primary human myotubes 
 
Lastly, we examined if FTO controls the expression of metabolic-related 
genes through the dynamic regulation of m6A level on mRNA transcripts. CA 
treated myotubes showed an increase in the level of m6A modification in total 
mRNA compared to untreated control (Figure 7.10). Consistent with this 
result, an increase in the level of m6A methylation in total mRNA was also 
































































Figure 7.10 FTO inhibition of primary 
human myotubes by CA (100 µM, 24h) and 
FTO knockdown (siRNA,5nM) prevents 




In this study, we demonstrate using two different approaches (siRNA and CA) 
that both FTO deficiency and FTO inhibition in primary human myotubes 
enhanced expression of genes involved in fatty acid oxidation and oxidative 
phosphorylation and decreased expression of genes involved in de novo 
lipogenesis, suggesting a shift from fat accumulation to fat oxidation in 
muscle. We also showed that FTO inhibition improved mitochondrial 
function, especially oxidative metabolism and completely prevented the 
inhibitory effect of palmitate on basal glucose uptake.  
 
Our results are consistent with the study of Grunnet et al who showed that 
FTO mRNA expression was negatively associated to basal and insulin 
stimulated lipid oxidation rate in young and elderly nondiabetic twins(273) 
and with the study of Bravard et al who showed that increased expression of 
FTO in human myotubes increased the rate of lipogenesis compared with 
GFP-overexpressing myotubes(274). In contrast, Church et al reported that a 
dominant missense mutation in mouse FTO gene (FTO 1367F) upregulated 
FASN levels suggesting enhanced fat synthesis in muscle. However, there was 
no increase in fat depots in muscle, therefore a conclusion regarding the 
association between FTO and lipid storage in muscle could not be drawn in 
this study(159). We sought to determine whether changes in lipid metabolism 
might be occurring through PGC1A, a key transcriptional co-activator that 
regulates mitochondrial biogenesis and oxidative metabolism in muscle. 
Interestingly, the methylation of the promoter of PGC1A was altered in 
 166
muscle of T2D patients(275). We found an increase in PGC1A mRNA levels 
with FTO inhibition suggesting that PGC1A may be involved in FTO-induced 
alterations of mitochondrial genes. Similarly, Bravard observed that PGC1A 
and FTO mRNA levels were regulated in an opposite manner in T2D 
patients(274). In contrast, Grunnet et al demonstrated a positive correlation 
between FTO with PGC1A and mitochondrial OXPHOS genes in non-diabetic 
young and elderly twins(273). Merkestein et al recently showed that PGC1A 
was upregulated in mice with 2 additional copies of FTO (FTO-4 mice)(276).  
 
FTO inhibition markedly enhanced spare respiratory capacity (SRC) possibly 
due to higher level of OXPHOS genes such as ATP5J2 and PGC1A. SRC is 
the amount of extra ATP that can be produced by oxidative phosphorylation at 
maximal respiratory capacity in response to increased stress or work and is 
associated with long-term cellular survival and function(277-280). A lack of 
SRC has been correlated with a variety of pathologies including heart 
diseases, neuro-degenerative disorders, and cell death in smooth muscle(279, 
281, 282). Recently Keuper et al showed that SRC permits primary adipocytes 
cells to maintain ATP homeostasis under hypoglycemic conditions and may 
also allow additional metabolic scope for energy dissipation(283). SRC is also 
increased in skeletal muscles after endurance exercise(172) or as a 
consequence of caloric restriction. This finding is consistent with a study 
showing reduced complex I-mediated ATP synthesis in FTO overexpressed 
C2C12 myotubes(274).  Grunnet et al observed faster recovery rates of PCr 
and Pi in oxidative muscles after exercise in homozygous carriers of the FTO 
risk allele suggest therefore a higher capacity for aerobic ATP synthesis in 
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these subjects. However, no association between the FTO genotype and FTO 
expression in the vastus lateralis muscle was found, therefore the association 
between FTO expression and mitochondrial efficiency cannot be 
concluded(284). Many studies in trained individuals have demonstrated that 
endurance exercise enhanced maximal mitochondrial respiratory capacity(172, 
285), fatty acid oxidation(286) and ATP production(287) in muscle, 
suggesting that FTO may have a role in the regulation of mitochondrial 
oxidative phosphorylation that contributes to the energy demands of the 
exercising muscle.  
 
Notably, FTO inhibition had no effect on proton leak but yet an increase in 
UCP3 mRNA expression was observed. Since proton leak is considered to be 
physiologically important in energy expenditure as it accounts for 20–25% of 
basal metabolic rate in rats(243, 288), our results suggest that CA may not 
have an impact on energy expenditure or may regulate energy expenditure by 
alternative mechanisms such as futile substrate cycling of fatty acids and 
triglycerides(75), Ca2+ cycling(11) or protein turnover not measured in this 
study(289). Our results are consistent with previous finding of unaltered 
mitochondrial uncoupling in brown adipose tissue of FTO deficient mice(158) 
but different from that observed in human adipocytes, where FTO deficiency 
induced mitochondrial uncoupled respiration and UCP1 mRNA 
expression(290). Evidence for a role of UCP3 in proton leak comes from 
studies on UCP3 knockout mice, which have lower state 4 respiration (116, 
291). It is also shown that obese diet-resistant women have lower 
mitochondrial state 4 respiration and UCP3 mRNA levels in muscle compared 
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to diet-responsive subjects(99). Evidence against UCP3 being involved in 
proton leak includes the finding that fasting increased UCP3 mRNA level in 
muscle despite a reduced metabolic rate(253). Elevation of UCP3 by a high fat 
diet in males did not affect mitochondrial proton leak in vivo(123). Our results 
agree with these findings that UCP3 may not be involved in mitochondrial 
proton leak. The upregulated UCP3 mRNA expression observed in our study 
could be a mechanism to sustain increased rates of lipid oxidation via export 
of FFA anions out of mitochondrial matrix. Under conditions of high fatty 
acid flux into mitochondria via CPT1B, excessive accumulation of long chain 
acyl-CoA molecules would be harmful to membranes and sequester CoA, 
thereby impairing fat oxidation. To prevent these events, upregulation of 
mitochondrial thioesterase cleaves the acyl-CoA allowing export of the fatty 
acid anion via UCP3(292). Elevated circulating FFA levels are associated with 
increased muscle UCP3 expression in fasting, high-fat feeding and obesity, 
independent of changes in energy expenditure(127, 293) 
 
We next sought to determine whether inhibition of FTO could improve insulin 
signaling since FTO inhibition resulted in a reduction of de novo lipogensis 
and increase in fatty acid oxidation. CA was able to alleviate the reduction in 
glucose uptake caused by palmitate acid, however did not significantly alter 
basal and insulin-stimulated Akt (Ser473) phosphorylation, suggesting that 
FTO may not exert its metabolic effects via the IRS1/PI3K pathway. 
Similarly, Bravard et al observed that silencing FTO in human myotubes did 
not significantly modify basal Akt (Ser 473) phosphorylation(274). We 
postulate that FTO may affect other signaling pathways such as AMPK(294) 
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or p38 MAPK(295) pathways that are activated by exercise.   
 
We also demonstrated that FTO regulates fatty acid metabolism and energy 
homeostasis by increasing the level of m6A in FTO-targeted genes. 
Importantly, many of the FTO-regulated genes that were associated with 
obesity contain m6A sites in their mRNA transcripts. Acaca, Atf6, Bip, Gcdh, 
Irs1, Perk, and Xbp1 are not only involved in FTO regulated metabolic 
pathways, they also contain m6A sites(270) 
 
Overall, our results suggest that FTO inhibition by CA improves mitochondria 
functions especially oxidative metabolism in human skeletal muscle. It also 
causes an increase in fatty acid oxidation, which is coupled with a decrease in 
lipogenesis. This likely suggests a shift from lipid accumulation to lipid 
oxidation. It also improves basal glucose uptake. Hence, our results are 
consistent with the higher metabolic rate and lower fat mass observed with 
FTO-/- mouse. Collectively, these findings suggest that pharmacologic 







Chapter 8 : Conclusions and future directions 
 
Firstly, we evaluated the validity of FAO/WHO/UNU equation and other 
commonly used prediction equations, Harris Benedict, Mifflin et al and Owen 
et al for resting energy expenditure (REE) in a sample of healthy Singaporean 
Chinese men. The results showed that the Owen equation provided a valid 
estimation of REE in Singaporean Chinese men at a group level. However, the 
individual errors of the equations were unacceptable high and may have 
limited utility in making clinical decisions on nutritional requirements. 
Therefore, in individuals where a precise determination of REE is indicated, 
measurement by indirect calorimetry instead of the prediction of REE using 
equations is highly recommended. 
 
Next, we explored the impact of ethnicity on REE and metabolic flexibility 
(MF) in Chinese, Asian-Indian and Malay men. We have found that Asian 
Indian men exhibit lower REE than Chinese men for the same body weight.  
These differences may contribute to the higher prevalence of obesity in this 
ethnic group.  Lower REE in Asian-Indian men may be mediated by smaller 
size of high metabolic rate organs in the trunk and the brain. To prevent 
obesity in Asian-Indians, the recommended dietary allowance for energy 
intake should take into account the lower REE in this ethnic group, and not 
only on age and body weight as currently recommended by the WHO.  
 
MF, as measured by RQ (iAUC) was independently associated with obesity 
but not insulin resistance in Chinese, Asian-Indian
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ISI was associated with RQ (iAUC) but the association was completely 
attenuated by adjustment for obesity. The relationship between MF and 
obesity is modulated by ethnicity. In lean individuals, Chinese had lower MF 
than Malays and Indians.  However, in overweight/obese individuals, MF was 
similar between ethnic groups. These ethnic differences seem to relate to 
differences in the propensity to increase glycolysis, rather than suppression of 
fat oxidation, after a meal.  Thus, altered glycolysis should be considered 
when examining inter-individual differences in MF. Greater propensity for 
carbohydrate oxidation and suppression of fat oxidation in lean Asian-Indians 
and Malays compared to lean Chinese, may predispose them to deplete 
glycogen stores and ingest more total energy, leading to greater obesity.  
 
We further sought to examine potential inter-individual differences in skeletal 
muscle characteristics that can explain variability in REE and MF and also the 
impact of ethnicity on molecular factors affecting skeletal muscle energy 
metabolism. Variability in REE after adjustment for FFM and fat mass was 
not associated with mitochondrial respiration in Chinese and Asian-Indian 
human myotubes. Therefore, skeletal muscle may not have the intrinsic 
capacity for regulating resting energy metabolism via mitochondrial proton 
leak. Greater mitochondrial oxidative capacity in lean Asian-Indians compared 
to Chinese may explain the greater MF observed in the former.  
 
Finally, we characterized the function of FTO in skeletal muscle energy 
metabolism and fuel utilization. Inhibition of FTO m6A demethylation activity 
by CA improved mitochondria function especially oxidative metabolism. CA 
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also caused an increase in fatty acid oxidation, which is coupled with a 
decrease in lipogenesis. This likely suggests a shift from lipid accumulation to 
lipid oxidation. CA was also able to improve basal glucose uptake. FTO 
regulates fatty acid metabolism and energy homeostasis by modulating the 
level of m6A in FTO-targeted genes. Collectively, these findings provides 
string support that pharmacologic inhibition of FTO could be a viable 
therapeutic strategy for obesity. We hope to extend of our research to animal 
models. It will be of tremendous clinical interest to determine if FTO inhibitor 
could bring about similar beneficial metabolic effects in animal models. It is 
also of tremendous medical interest to map out the RNAs that are the target of 
FTO's demethylase activity, in order to identify the mRNA targets that give 
rise to the obesity phenotypes, and to better understand the biological 
pathways that are regulated by FTO. We hope to build a comprehensive map 
of FTO-regulated m6A epitranscriptome in human myotubes. In particular, we 
seek to systematically identify the full range of FTO-targeted gene transcripts/ 
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